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Ethnobotanical enquiries often lead to the discovery of phytocompounds with 
pharmacological activities. Against this background a comparative and quantitative 
evaluation of the phytochemical and antioxidant activity of extracts from six Croton species; 
C. gratissimus Burch., C. sylvaticus Hochst., C. menyhartii Pax, C. pseudopulchellus Pax, C. 
steenkampianus Gerstner and C. rivularis Müll.Arg., all collected from KwaZulu-Natal 
(KZN), South Africa, was conducted. The analysis included a comparison of the different 
plant organs to explore the possibility of using leaves rather than bark for medicinal purposes. 
The latter would result in less destructive harvesting and would contribute to sustainable use 
of these medicinal plant resources.  
Extraction of the different plants and their organs were done in water and, in different 
organics solvents, including methanol (MeOH), dichloromethane (DCM), and petroleum 
ether (PE). The extracts were screened for antibacterial and antifungal activities using the 
microdilution technique. All of the tested plant samples showed some notable antibacterial 
activity in one or two of their organs, except for C. rivularis, which was the only species in 
the list that had no record of medicinal use. The most potent antibacterial activity was 
exhibited by the dichloromethane (DCM) extracts of C. steenkampianus leaves and the 
petroleum ether (PE) extracts of C. pseudopulchellus stem bark, both sampled from the 
Durban Botanic Gardens, which yielded a minimum inhibition concentration (MIC) value of 
0.04 mg/ml against Enterococcus faecalis (E. faecalis). The DCM stem bark and leaf 
extracts, as well as the PE twig extracts of C. pseudopulchellus, (Durban Botanic Gardens) 
also exhibited noteworthy activities against S. aureus (MIC value of 0.08 mg/ml). A broad 
spectrum of activity was observed in the DCM and PE twig extracts of C. sylvaticus collected 
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from Umdoni Park, with a MIC ranging from 0.31-0.94 mg/ml. This activity was against E. 
faecalis, Staphylococcus aureus (S. aureus) and Klebsiella pneumoniae (K. pneunomiae). 
Noteworthy antifungal activity against Candida albicans was only observed in one extract, 
the MeOH leaf extract of C steenkampianus collected at Kosi Bay. The MIC of this extract 
was 0.6 mg/ml. Water extracts did not show any antimicrobial activity. The results of the 
pharmacological study suggested that the aerial plant organs, such as the leaves and the twigs, 
could replace bark as they exhibited significant antimicrobial activity when compared to the 
preferred bark. The study also revealed that the same species collected from different regions 
may not necessarily exhibit similar biological activities, as pharmacological activities are as a 
result of the phytochemicals present in the plant, which are triggered by environmental 
stimuli.  
The phenolic profiles of aqueous (50%) methanol extracts obtained from the plants were 
assessed using the Folin and Ciocalteu (Folin C), butanol-hydrochloric acid and aluminium 
chloride assays. Aqueous (50%) methanol extracts were also run on thin layer 
chromatography plates and the plates were later stained with the Dragendorff reagent to 
determine the possible presence of alkaloids. Antioxidant activity was determined with two 
different assays, β-carotene /Linoleic model system and 1,1-diphenyl-2-picryl hydrazyl 
(DPPH) radical scavenging assay. The overall EC50 values of the different Croton species 
displayed by the DPPH assay ranged from 1.76 to 5.35 µg/ml. The β-carotene /Linoleic 
model system displayed antioxidant activity that ranged between 48.66 to 81.97%. In the 
phytochemical study; the leaf extracts of C. pseudopulchellus from Mkuze exhibiting the 
highest phenolic content at 23.8±1.1 mg GAE/g Dry Weight. The highest condensed tannin 
content was from the leaf extracts of C. gratissimus from Southport at a concentration of 
31.3± 0.1 mg CCE/g Dry Weight. The highest flavonoid content observed in the leaf extracts 
of C. gratissimus from Southport at a concentration of 31.2±0.7 mg CE/g Dry Weight. Higher 
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phytochemical contents were also observed in the leaves and twigs. These phytochemicals 
are believed to be the reason for most of the notable  antimicrobial activities exhibited by 
these plant organs. The mutagenic potential of the most biologically active Croton extracts 
was tested. An Ames with two Salmonella tester strains (TA98 and TA102) revealed that the 
species are not toxic as they did not produce His+ revertant colonies in Salmonella tester 
strains that were more than twice the number of His+ revertant produced by the positive 
control, Nitroquinoline-N-oxide (4-NQO). 
Standard DNA barcodes of the Croton species occurring in KZN were generated, since these 
are useful in plant identification and authentication. These were used to run a phylogenetic 
analysis in order to assess whether the phytochemical profile is clade-specific. The results 
showed that the quantity and quality of phytochemicals closely related species may vary. 
DNA barcoding may be a useful tool in medicinal plant identification, especially where 
fragments of the plants are traded and morphological identification is not possible.  
In this study, the biological activity of different parts of six Croton species occurring in KZN, 
was investigated with the aim of replacing bark as the source of local medicine with other 
plant parts (leave and twigs) that can be more sustainably harvested, as this will contribute to 
the conservation of these species.  
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1.1. Historical and current therapeutic use of plants 
Plants have been a reliable and valuable source of medicines throughout humankind‘s history 
and continue to be used by people in rural and disadvantaged communities as one of the 
primary sources of food and medicine (Chen et al., 2010, Tshisikhawe et al., 2012). 
Existing physical evidence indicates that the therapeutic use of plants dates back up to 60 000 
years (Halberstein, 2005). Due to the high prices and the lack of trust in synthetic drugs, 
medicinal plants remain the treatment of choice in various rural communities across the 
world (Halberstein, 2005, Fatemeh et al., 2018). Many people trust medicinal plants for 
their cultural relevance and the long history of use by their ancestors (Masevhe et al., 2015, 
Fatemeh et al., 2018). They have had great success in maintaining and restoring their health. 
Herbal medicines are believed to have several advantages over Western medicine, such as 
fewer side effects and greater affordability (Singh and Prakash, 2011). Mastering and 
understanding the use of plants for therapeutic gain and other human needs has taken humans 
a great deal of trial and error (Fatemeh et al., 2018). Some of their knowledge was obtained 
by observing monkeys and apes, as they are believed to use plants to treat their own ailments 
(Halberstein, 2005, Mamedov, 2012). Much of the knowledge of traditional plants has been 
passed down orally from generation to generation by traditional healers (Mamedov, 2012, 




Medicinal plant trade and demand in South Africa are rapidly growing and estimated to be 
worth about R270 million per annum, with over 700 plant species traded for medicinal 
purposes (Dold and Cocks, 2002). This increase in trade and demand for traditional 
medicinal plants in this country is threatening plant biodiversity. This is mostly due to the 
immense surge in unsustainable bark harvesting practices (Tshisikhawe et al., 2012). The 
depletion of natural resources such as medicinal plants causes concerns about the negative 
impact this will have on people and communities that rely on the plants for their livelihood, 
health care and financial income (Hamilton, 2004). 
Plant overexploitation was not a problem for the early humans as they had vast knowledge 
about medicinal plants; they valued and strived to maintain healthy ecosystems through 
sustainable practices (Tshisikhawe et al., 2012). Only skilled traditional healers were 
responsible for harvesting. They followed strict collection practices, which observed 
collection times and quantities (Williams et al., 2000). Nowadays, the increased demand for 
medicinal plants has led to the rise of many untrained harvesters who do not consider that 
plants may go extinct due to their unsustainable harvesting practices (Williams et al., 2000, 
Tshisikhawe et al., 2012).  
However, not all is lost. The conservation status of medicinal plants can be improved by 
developing sustainable use and harvesting practices. These include acquiring adequate 
information about the medicinal plants such as their distribution and the genetic diversity of 
wild populations and relatives. Furthermore, studies should be conducted that determine the 
annual yield of plants that can be harvested without damaging populations. This information 




1.2. Sustainable use of plants as medicine  
A rapid decrease in biodiversity has been observed in ecosystems globally. This decline not 
only limits the availability of medicinal plants, but also causes an imbalance in the ecosystem 
where many ecosystem services have been disturbed because certain species have been lost 
or have gone extinct (Shinwari and Qaiser, 2011). Indiscriminate harvesting has 
significantly contributed to the decline of species in ecosystems (Aremu, 2009). Unlike aerial 
parts harvesting, such as that of fruits and leaves, the harvesting of the roots, bulbs, or bark 
damages the plant. Bark harvesting is especially harmful when the tree is ring-barked, which 
disturb the tree‘s long term growth and reproductive activity (Williams et al., 2000). An 
observation made in South Africa is that the bark is the most harvested and sought after 
product in the traditional medicine market. The effects that bark harvesting has on medicinal 
plants in South Africa require attention from all research fields to preserve the country‘s rich 
floral heritage and traditional health care (Grace et al., 2002). The threat to biodiversity 
harms the livelihoods of many people that depend on and trade natural resources. This has led 
to a realization that there is an urgent need for sustainable use and conservation of all plants, 
all of which will only be successful when local communities are involved (Van Wilgen et 
al., 2013). 
Various agencies suggested the cultivation of medicinal plants to conserve the plants in the 
wild and minimize the pressure on wild resources. However, this method is not without its 
disadvantages and may not be the perfect solution to solve plant exploitation. Disadvantages 
include a decrease in genetic diversity and a lessened interest from locals to conserve wild 
populations (Schippmann et al., 2002). Some strategies listed as significant in promoting 
and achieving conservation include conducting studies on the habitat, distribution, and 
abundance of medicinal plants. Conducting studies on the spread of medicinal plant 
knowledge and use in various societies; studying medicinal properties, quality and the 
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interaction of the plants with their environment are also possible strategies of promoting and 
achieving plant conservation. These will be followed by the establishment of methods to 
monitor the sustainability of current harvesting processes of medicinal plants. Finally the 
implementation of sustainable harvesting methods (Hamilton, 2004). Several of the 
strategies mentioned above are covered in the current Croton study and, therefore, the results 
may be an example of the efforts to improve the conservation strategies of other medicinal 
plants. Schipmann et al. (2003) noted sustainable harvesting as an essential conservation 
strategy for wild-harvested plants, notwithstanding their significance to the economies of 
local communities. Schipmann et al. (2003) further explained that the main idea of 
sustainable harvesting involved conducting non-destructive harvests, thus maintaining the 
populations and ecosystem diversity. Hence this study focused on comparing various 
phytochemical and pharmacological properties of the plant parts of the studied Croton 
species.  
 
1.3. Role of plants in drug discovery 
The process of drug discovery from plants is multifaceted, with biological, botanical, 
ethnobotanical, and phytochemical expertise collectively integrated (Jachak and Saklani, 
2007). This process is often initiated by the efforts of ethnobotanists who research 
relationships between people and plants. Here, knowledge about indigenous use of plants as 
remedies by local herbalists gives clues to plants with pharmacologically active compounds 
(Cox and Balick, 1994). Pharmacological and phytochemical studies validate the selected 
plants' use and safety (Light et al., 2005). These plants may be potential cures for a range of 
ailments, including HIV/AIDS, malaria, Alzheimer's, pain, and cancer (Cox and Balick, 
1994, Jachak and Saklani, 2007).  
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The selection of plants as potential sources of novel drugs is considered advantageous 
because of their long history of use by humans. There is an expectation that bioactive 
compounds extracted from these plants would be less toxic to humans (Fabricant and 
Farnsworth, 2001). Some of the most prominent early plant-derived drugs include the most 
potent analgesics for chronic pain, such as codeine and morphine, which are obtained from 
opium poppy Papaver somniferum L.; the cardiac glycoside digoxin obtained from Digitalis 
species; aspirin derived from the bark of the willow tree (Salix sp.), atropine, a muscaric 
antagonist, obtained from Atropa belladonna L. and many more (Houghton, 1995, Brower, 
2008, Dutra et al., 2016). Medicinal plants have played a significant role in oncology 
therapeutics as well. About 60% of the drugs that have been used to fight cancer over the past 
century are plant-derived (Balunas and Kinghorn, 2005, Dutra et al., 2016). These plant-
derived chemotherapeutic agents such as taxol, camptothecin, vincristine, and vinblastine, 
have had a major impact in improving the treatment of various kinds of cancer (Raskin et al., 
2002, Shoeb, 2006)  
Studies have proposed traditional based medicine as a reliable alternative treatment for fever, 
cold, cough, chest pain, asthma, throat and ear infection worldwide. Thus, medicinal plants' 
significance in treating respiratory diseases is supported (Dutra et al., 2016). The proven 
efficacy of various medicinal plants tested against a wide range of respiratory diseases 
globally has led to hopes that medicinal plants could be used as potent medicine against the 
current pandemic; COVID-19 (Khan et al., 2020). Plants continue to be a relevant source of 
leading pharmaceuticals (Raskin et al., 2002). This is attributed to the ethnobotanical 
approach, which has proven to be highly productive (Cox and Balick, 1994). Together with 
ethnopharmacology, this expertise could play a significant role in the global HIV/AIDS 
pandemic (Light et al., 2005). A more recent drug discovery approach involves using various 
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techniques to standardize herbal medicine and interpret analytical marker compounds 
(Jachak and Saklani, 2007).  
 
1.4. Medicinal plant misidentification and use of adulterants  
The increased use and international trade of medicinal plants have given rise to more 
challenges, such as the inability to instantly and accurately identify traded plants, mainly 
because only part of the plant is being sold (Chen et al., 2010). Accurate identification and 
authentication procedures for medicinal plants are crucial for people‘s safety and health. 
These procedures will help prevent problems, especially when plants are traded (Techen et 
al., 2004). The traditional medicine industry is known to be plagued with fraudulent 
activities, whereby medicinal plant adulterants and substitutions of certain medicinal plants 
sold to people in the absence of the required plants. The substitutions are usually closely 
related species. This causes great concern because the adulterant may not be effective or 
could possibly be toxic (Techen et al., 2004, Techen et al., 2014). 
Consumption and use of misidentified herbs have been the leading cause of death in the 
traditional medicine industry (Rates, 2001, Ndhlala et al., 2011). In order to use medicinal 
plants and the indigenous knowledge associated with them more effectively with little to no 
identification problems, there is a need to develop DNA barcode-based identification tools, 
chemical profiles and the use of phylogenetic analysis to identify clades of species that 
contain high levels of the desired phytochemicals (Singh and Prakash, 2011). Analysis of 
plant DNA barcodes is a reliable and effective pharmacognostic method of solving plant 
identification problems caused by identification uncertainty (Selvaraj et al., 2012). A 
medicinal plant DNA barcode reference library could be created and used to support plant 
identification (Ganie et al., 2015).  
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1.5. The genus Croton  
The genus Croton belongs to the family Euphorbiaceae and consists of about 1300 species 
(Salatino et al., 2007). Many of them have a long history of use in traditional medicine in 
South America, Africa, and Asia (Salatino et al., 2007, Adelekan et al., 2008). Ailments that 
Croton species are commonly used for include fever, digestive problems, cancer, 
constipation, hypertension, external wounds, malaria, inflammation, diabetes, chest 
complaints, rheumatism, bleeding gums, cough, pain, and ulcers (Salatino et al., 2007). 
Despite their extensive use, there have been only a few scientific studies to validate the 
healing properties and efficacy of local Croton species in South Africa (Van Wyk et al., 
1997). Croton is known for its chemical complexity; species within this genus contain a wide 
variety of chemical compounds (Van Wyk et al., 1997). In KwaZulu-Natal (KZN) and 
nearby Eswatini/southern Mozambique, five Croton species occur (Table 1.1) and all are 
used for medicinal purposes. The two most commonly used species are Croton gratissimus 
Burch. and Croton sylvaticus Hochst. These two Croton species share a common Zulu name 
‗umahlabekufeni,‘ and their bark is mostly used in treating the same ailments (Van Wyk and 
Gericke, 2000).  
 
1.6. Morphology, geographical distribution and ethnomedicinal uses of Croton 
species found in KZN 
Croton gratissimus Burch. (Lavender Croton) is a shrub or tree that grows to a height of 10 
meters. The tree is slender with drooping leaves and a crown with hanging terminal branches 
that extend in a V-shape. The leaves have a dark-green colour on the upper surface and the 
lower surface is silver to grey with brown spots (Coates Palgrave, 2000). It is mostly 
distributed in Africa's tropics, over various forest types, and a wide range of altitudes, 
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frequently associated with rocky outcrops. The tree occurs in warm and dry regions on stony 
and sandy hillsides. When crushed, the leaves produce a pleasant smell that can be used in 
perfumes (Boon, 2010).  
This is one of the many plants used by the Venda people to treat candidiasis and other fungal 
infections (Masevhe et al., 2015). All of its parts are known to have medicinal value (Van 
Vuuren and Viljoen, 2008). The leaves are used to make a decoction to treat coughs 
(Mulholland et al., 2010) and sores associated with sexually transmitted infections (Van 
Vuuren and Naidoo, 2010). The bark is used to treat respiratory illnesses such as intercostal 
neuralgia (Mulholland et al., 2010), stomach disorders, and bleeding gums (Mthethwa et 
al., 2014). It also alleviates skin inflammation, wounds, and chest pain (Hutchings, 1996). A 
study done by (Mthethwa et al., 2014) confirmed that extracts from C. gratissimus exhibit 
antimicrobial and anti-HIV properties. Thus it may have potential as both an antiviral and an 
antimicrobial agent. Even with its extensive use, there is still a need for further scientific 
studies to validate the therapeutic properties that C. gratissimus claimed to have by users 
(Van Vuuren and Viljoen, 2008). 
 
Croton sylvaticus Hochst. (Forest Croton) is a semi-deciduous shrub or large tree (Boon, 
2010). The bark is grey and becomes rough with age. It has large, smooth, alternating leaves, 
which are ovate with a pointed apex. It is commonly found in forests or dense woodlands 
(Boon, 2010).  
Studies have shown that Croton sylvaticus is traditionally used to treat about 24 human and 
animal diseases (Maroyi, 2017). It is used to treat uterine and abdominal disorders, fever, and 
internal inflammation (Hutchings, 1996, Selowa et al., 2010). It is also used to treat 
respiratory ailments, cough, tuberculosis (Sawhney et al., 1978), rheumatism, and pleurisy, 
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(Netshiluvhi, 1996) and is used as a purgative (Elgorashi et al., 2002). Extracts from leaves 
are used to treat ear infections, malaria and cancer (Maroyi, 2017). The leaves are also used 
to prepare a poultice for treating pleurisy (Palgrave, 2002). The bark is highly sought after 
and stocked in the South African muthi markets (Maroyi, 2017).  
 
Croton steenkampianus Gerstner (Maputaland Croton) is a shrub or tree. It grows on edges of 
sand forests and thickets in Maputaland (Boon, 2010). It has smooth, basal much-branched 
stems. The leaves are large (12 × 7 cm) and mostly ovate-heart shaped with a pointed apex, 
dark green at the top, and grey on the underside (Boon, 2010). This plant is endemic to 
specific areas in central Africa and the eastern part of Southern Africa (Coates Palgrave, 
2000). 
C. steenkampianus is used to treat back pain, joints problems, and rheumatism (Hutchings, 
1996, Selowa et al., 2010). Steam from a leaf decoction is inhaled for pain relief (Pooley, 
1993, Adelekan et al., 2008).  
 
Croton pseudopulchellus Pax (Small Lavender Croton) is a shrub or small tree that grows up 
to 3-5 m tall (Boon, 2010). It looks similar to C. gratissimus but is shorter, and the leaves are 
6 × 2 cm in size, with red to brown scale dots on the surface (Hargreaves, 1991). It is multi-
stemmed with a rough brown-grey bark when matured (Boon, 2010)  
The leaves are used as an ointment by Tanzanians to relieve chest infirmities. C. 
pseudopulchellus is known to have antiviral properties due to its action against tussive 
conditions (Langat et al., 2012). The species is also used to treat asthma (Hargreaves, 1991) 




Croton menyharthii Pax (Rough-leaf Croton) is a small shrub that grows up to 4 m tall 
(Boon, 2010). It is similar to C. gratissimus; however, its leaves are smaller (up to 7 x 3 cm) 
with yellow scale speckles scattered on the surface (Hargreaves, 1991). The plant has elliptic 
to ovate-lanceolate, dull-green rough hairy leaves and hairy twigs. Its distribution is scattered 
across South Africa, usually forming dense stands in bushveld and thickets (Boon, 2010).  
The leaves, roots, and root bark of C. menyhartii have been used in folk medicine to manage 
and treat intestinal obstruction, ascites, hepatitis, and dysmenorrhoea (Aderogba et al., 
2013).  
 
Croton rivularis Müll.Arg. is a small shrub growing up to 2 m tall, commonly found in 
bushveld along rivers (Boon, 2010). Stems and twigs are hairy. Leaves are dark green and 
ovate-lanceolate in shape (up to 12 ×7 cm). They have unevenly serrated margins and are 
covered in star-shaped hairs (Boon, 2010).  
To the best of our knowledge, there is no record of the medicinal use of C. rivularis. 






Figure 1.1: Images of Croton species that occurring in KZN, South Africa. a=C. gratissimus, 
b=C. sylvaticus, c=C. steenkampianus, d=C. pseudopulchellus, e=C. menyhartii, and f=C. 
rivularis. Images a-e by Tanya Mathe and image f by Graham Grieve.
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1.7. Disease-causing bacteria 
1.7.1. Staphylococcus aureus  
Staphylococcus aureus is a Gram-positive, facultative aerobic bacterium from the family 
Staphylococcaceae that can also grow in the absence of oxygen by using alternative terminal 
electron accepters or fermentation (Masalha et al., 2001). This bacterium can adapt to 
different environments (Balasubramanian et al., 2017). Humans are natural carriers of non-
pathogenic S. aureus; these are more common than pathogenic strains (Chambers, 2001). 
However, S. aureus has proven to be a human pathogen responsible for a wide range of 
nosocomial infections (Chan and Foster, 1998). It is also known to occur on the skin (Feng 
et al., 2000). S. aureus infection is mostly responsible for soft tissue, skin, joint, bone 
endovascular, and respiratory disorders (Lowy, 1998). Even though it is rare S. aureus does 
cause urinary tract infections (UTI), with symptoms such as fever, dysuria, altered mental 
status, hematuria, and suprapubic pain (Tong et al., 2015). Skin infections caused by the 
presence of S. aureus include cutaneous abscesses, impetigo, pyomyositis, and folliculitis 
(Balasubramanian et al., 2017). 
 
1.7.2. Escherichia coli  
Escherichia coli is a Gram-negative, rod-shaped bacterium from the family 
Enterobacteriaceae. The bacterium grows in both aerobic and anaerobic conditions (Croxen 
et al., 2013). E. coli is common in humans' gastrointestinal tract (Feng et al., 2000). 
Although it is not pathogenic, there are some pathogenic strains, causing extra-intestinal 
diseases and diarrhea. Different variants of E. coli (pathotypes or pathovars) have been 
studied and attributed to globally cause disease and fatalities (Croxen et al., 2013). 
Conditions related to the different E. coli pathotypes include enteric diseases with symptoms 
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ranging from diarrhea to severe dysentery. When colonizing the urinary tract, some E. coli 
pathotypes may result in cystitis or pyelonephritis or cause extra-intestinal infections, in 
addition it can cause septicemia and meningitis (Donnenberg and Whittam, 2001). 
 
1.7.3. Klebsiella pneumoniae 
Klebsiella pneumoniae is a Gram-negative, non-motile bacterium of the family 
Enterobacteriaceae. It is found widely spread in the environment and is found to inhabit the 
human gastrointestinal tract (Lawlor et al., 2005). K. pneumonia is also present as a 
saprophyte in the intestinal tract and the nasopharynx (Podschun and Ullmann, 1998). 
Various K. pneumoniae infections have been shown to occur after gastrointestinal 
colonization, and the gastrointestinal tract is known to transmit bacteria (Struve and 
Krogfelt, 2004). Numerous diseases can result from K. pneumonia infection; these include 
bacteremias, urinary tract infections, liver abscesses, and pneumonia. Hyper-virulent and 
antibiotic-resistant strains of K. pneumoniae have emerged and spread with time; this has 
resulted in a wide range of people being susceptible to infections. This has made it hard to 
treat (Paczosa and Mecsas, 2016).  
 
1.7.4. Enterococcus faecalis 
E. faecalis is a commensal Gram-positive bacterium from the family Enterococcaceae 
(Shioya et al., 2011). It is a fermentative, non-spore forming, facultative anaerobe, with the 
majority of its strains being non-motile and non-hemolytic (Rôças et al., 2004). E. faecalis 
was listed as one of the primary causative agents of urinary tract infections (Shankar et al., 
2001). E. faecalis causes wound infections such as intra-abdominal abscesses, peritonitis, and 
infected surgical wounds. Entry of E. faecalis in the genital or gastrointestinal tract leads to 
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bacteremia, followed by E. faecalis colonizing the heart tissue and producing acute or sub-
acute bacterial endocarditis (Guzman et al., 1989). It has also been found that E. faecalis 
occupies the oral cavity where it causes endodontic infections (Rôças et al., 2004). In a study 
conducted by Rôças et al. (2004) it was revealed that the prevalence of E. faecalis is 
commonly associated with persistent endodontic infection or failed endodontic therapy than 
with primary infection. 
 
1.8. Fungi as a human pathogen 
Research done on fungi has estimated the number of existing fungal species to be 
approximately 611 000, with 600 species being human pathogens (Mayer et al., 2013). The 
infections caused by fungi in humans range from mild skin infections to severe dermal and 
lethal systematic infections (Mayer et al., 2013). A high percentage of fungal infections 
clinically diagnosed are related to pathogens from the genera Aspergillus, Candida, and 
Cryptococcus. These fungi are ubiquitous and have been the cause of high mortality rates 
(Karkowska-Kuleta et al., 2009). Fungal species were rated the fourth common cause of 
nosocomial infections in the United States of America and caused 50% death of infected 
individuals (Mayer et al., 2013). In review based on scattered data Brown et al. (2012) 
estimated that the mortality rate associated with fungal infections has been higher than 50%. 
This has been a cause of great concern in the medical sector (Brown et al., 2012).  
Various factors are responsible for this alarming rise in mortality, even after intensive 
antifungal drugs have been administered to the patients. These include the development of 
antifungal drug resistance by the pathogens, late diagnosis of the cause of disease in the 
patient, and immunodeficiency in the patient (Karkowska-Kuleta et al., 2009). Ninety 
percent of HIV infected individuals contract at least one fungal infection. These fungal 
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infections are responsible for the mortality of about 10-20% of these HIV infected individuals 
(Samie et al., 2010). It is interesting to note that most healthy individuals rarely contract 
fungal infections, and if contracted, their immune system can fight them off without 
medication assistance (Brown et al., 2012). Just as in the case of bacteria, many fungal 
species have developed resistance against a wide range of commercial antifungal agents. 
However, most useful drugs are expensive and inaccessible to most people (Samie et al., 
2010). One of the most common human pathogens is Candida albicans.  
Candida has been proven to be a highly opportunistic pathogen mostly prevalent in immune-
compromised patients like those infected with HIV (Motsei et al., 2003, Amoo et al., 2011, 
Mukanganyama et al., 2011).  
With the alarming increase in HIV/AIDS infections in South Africa, Candida's opportunistic 
infections become unmanageable, thus requiring an intense search for alternative control 
methods or sources of medicine (Samie et al., 2010). Some of the most common infections 
caused by Candida are oral or vaginal candidiasis and lethal systematic infections (Motsei et 
al., 2003). While C. albicans is notorious for causing pathogenic infections in humans, it may 
also form part of the normal micro-flora in most individuals, residing commensally in most 
healthy individuals (Naglik et al., 2003, Mayer et al., 2013). In the case of an imbalance in 
the normal micro-flora or if the immune system is compromised, Candida species become 
pathogenic (Naglik et al., 2003).  
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1.9. Aims and objectives  
The aims and objectives of this study were: 
 to investigate and compare the antibacterial and antifungal properties of different 
Croton species found in KZN and parts of the plants;  
 to analyse and compare the phytochemical composition of different Croton species 
and various plant parts:  
 to investigate the genotoxicity of the various species and their parts to determine their 
safety as medicines; 
 to provide DNA a barcodes for locally sourced specimens of all the Croton species 
occurring in KZN; 
 to perform a basic phylogenetic analysis in order to confirm that sequences of KZN 
specimens group with other existing of the same taxon collected elsewhere and 
establish the phylogenetic relationships of taxa previously not included in any study; 
and  
 to investigate if phylogenetic relatedness influences phytochemical properties. 
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CHAPTER 2 
Antimicrobial susceptibility testing 
 
2.1. Introduction 
Waksman (1947) and Willey et al. (2008) defined antibiotics as chemical substances of 
microbial origin that possess the ability to control and inhibit the growth and/or metabolic 
activities of bacteria. Millions of lives have been spared over the past decades through the use 
of antibiotic therapy (Abdallah, 2011, Yadav and Agarwala, 2011). However, the extensive 
use and misuse of antibiotics have resulted in the emergence of different kinds of antibiotic-
resistant bacterial strains (Hart and Kariuki, 1998, Selowa et al., 2010). Some pathogenic 
strains have developed resistance to more than one antimicrobial agent (multiple drug-
resistance), whereas others resist the effects of nearly all known antibiotics (Levy and 
Marshall, 2004, Levy, 2005). For instance; nearly all Staphylococcus aureus strains 
worldwide have developed resistance to penicillin (Gibbons, 2005, Sibanda and Okoh, 
2007, Hemaiswarya et al., 2008, Chambers and DeLeo, 2009). Similarly, Escherichia coli, 
Klebsiella pneumoniae and Enterococcus faecalis have all developed some kind of resistance 
to some of the currently available antimicrobial agents (Tenover, 2006, Abdallah, 2011). 
Drug-resistant pathogens cause treatment failures (Sibanda and Okoh, 2007, Abdallah, 
2011) and hence cause spikes in morbidity and mortality rates especially in the wake of the 
HIV/AIDS pandemic (Levy and Marshall, 2004, Samie et al., 2010). The unprecedented 
evolution and global spread of anti-infection resistant pathogens necessitates an urgent need 
to develop novel and effective therapeutic drugs (Ahmad and Beg, 2001, Gibbons, 2005, 
Brown et al., 2014).  
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Plants can be a reliable source of therapeutic compounds as they contain bioactive secondary 
metabolites which they produce as part of their natural defence system (Bennett and 
Wallsgrove, 1994, Jachak and Saklani, 2007). The process of drug discovery from plants is 
multifaceted, with biological, ethnobotanical and phytochemical expertise collectively 
integrated (Jachak and Saklani, 2007). This process is often initiated by the efforts of 
ethnobotanists to research relationships between people and plants. Here knowledge about 
indigenous use of plants as remedies by locals gives clues of plants with possible 
pharmacological compounds (Cox and Balick, 1994). Pharmacological and phytochemical 
bioassays often validate the traditional use of medicinal plants and also ascertain their safety 
(Light et al., 2005). The first medicines produced from these plants are usually in the form of 
crude drugs such as tinctures, teas, poultices, powders and other herbal formulations 
(Balunas and Kinghorn, 2005, Jachak and Saklani, 2007). About 109 antibacterial drugs 
were approved between the years 1981 and 2006; from these 69% were derived from natural 
products, and, 21% of the antifungal drugs originated from natural products or compounds 
that resemble natural products (Newman, 2008, Savoia, 2012). 
Croton species are used widely in South African traditional medicine (Hutchings, 1996). 
Detailed investigations aimed at validating the traditional use of various Croton species were 
previously conducted by Van Vuuren and Viljoen (2008) and Langat et al. (2011). 
However, none of the studies focused on comparing the pharmacological properties of the 
species growing in different regions. The current study was designed to compare the 
antibacterial and antifungal efficacy of different Croton species occurring within different 
parts of the KwaZulu-Natal province, South Africa. This study further compares the 
antibacterial and antifungal activities of the different plant organs of the various Croton 
species occurring in KwaZulu-Natal province, South Africa. The results from this 
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comparative study will be beneficial in the efforts of addressing the problem of over 
harvesting and exploitation of medicinal plant. 
2.2. Materials and methods 
2.2.1. Plant material harvest and preparation of samples 
Information on the location of different Croton species in the KwaZulu-Natal (KZN) 
province, South Africa was obtained from the Bews Herbarium (NU), University of 
KwaZulu-Natal (UKZN), Pietermaritzburg (PMB), South Africa. Different organs of the 
plants (leaves, twigs and stem bark) were collected from different geographical locations 
within KZN. The identity of the species was confirmed by Alison Young and Benny 
Bytebier, Curator, Bews Herbarium, UKZN-PMB and voucher specimens (Table 2.1) were 
prepared and deposited at the same herbarium. Once harvested, different plant parts were 
oven-dried (50 C), ground in a milling machine to fine powders and stored at room 
temperature in brown paper bags for further use.
   
 20  
 
Table 2.1: Croton species collected in KwaZulu-Natal, south Africa, with their voucher and Bews Herbarium (NU) barcode numbers 
Plant species Locality and date of collection Voucher and barcode number 
Croton gratissimus Burch. Southport–20 April 2017 T2-NU0090740 
Durban Botanic Gardens-24 May 2017 T6-NU0090736 
Muden5–26 January 2018 T19-NU0087082 
Croton sylvaticus Hochst. Southport–20 April 2017 T3-NU0090725 
Umdoni Park-20 September 2017 T11-NU0087085 
Vernon Crook-21 September 2017 T14-NU0090728 
Ntunjambili–9 May 2017 T5-NU0090731 
Croton steenkampianus Gerstner  Durban Botanic Gardens-24 May 2017 T7-NU0090730 
Kosi Bay-16 November 2017 T18-NU0087087 
Croton pseudopulchellus Pax Durban Botanic Gardens-24 May 2017 T8-NU0090737 
Mkuze Game Reserve–15 November 2017 T17-NU0087084 
Southport-20 September 2017 T12-NU0090738 
Croton menyhartii Pax Kranskop-9 May 2017 T4-NU0090732 
Mkuze Game Reserve–14 November 2017 T16-NU0087086 
Croton rivularis Müll.Arg Umzimkhulu Valley-16 February 2018 T20-NU0087083 
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2.2.2. Extraction of plant material 
Dry and powdered plant materials were mixed with different solvents (distilled water, 
petroleum ether (PE), 80% methanol (MeOH) and dichloromethane (DCM) at a ratio of 10:1 
(10 ml/g). Various phytochemicals are extracted in solvents of differing polarity based on 
their chemical composition, since no one solvent can accurately extract all of the 
phytochemical and antioxidant compounds found in plant material (Lin and Giusti, 2005, 
Nawaz et al., 2020). Different solvents were used to facilitate extraction of all biologically 
active compounds in the plant material. The resultant solutions were stirred at room 
temperature for 12 h at 150 rpm in a rotary shaker (Edmund Bühler, Tübingen, German), 
after which they were sonicated on ice for 1 h (Julabo GMBH, Germany). The plant extracts 
(only solvent extracts) were then filtered under vacuum using Whatman No 1 filter paper in 
Büchner funnels and later concentrated using a rotary evaporator (Heldolph vv2000, 
Germany) at 35 C. The concentrated extracts were transferred to glass pill vials and dried 
under a fan. All water extracts were freeze-dried (Virtis freeze-drier, Benchtop Pro). Both 
aqueous and organic solvent extracts were stored in the dark at 10 C for further use. Dry plant 
material were weighed and resuspended in 20% dimethyl sulfoxide (DMSO) to make a final 
concentration of 10 mg/ml. 
 
2.3. Antibacterial assay 
2.3.1. Bacterial stock preparation 
A colony of each bacterial strain (Escherichia coli ATCC 11775, Klebsiella pneumoniae 
ATCC 13883, Staphylococcus aureus ATCC 12600 and Enterococcus faecalis ATCC 19433) 
was inoculated in 5 ml sterile Muller-Hinton (MH) broth and incubated over night at 37 C in 
a water bath with an orbital shaker (40 rpm). Agar plates were prepared by pouring 20 ml of 
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hot sterile MH agar into Petri dishes and were allowed to cool and set. The bacterial test 
strains were each then streaked on different agar plates and incubated at 37 C for 24 h. The 
resulting plates were stored in a refrigerator (4 C) and the bacterial strains were sub-cultured 
on a monthly basis to maintain cell viability. 
 
2.3.2 Microdilution bioassay  
The microdilution antibacterial assay (Eloff, 1998) was used to determine the antibacterial 
activity of the plant extracts. Single colonies from the test bacterial strains (E. coli, K. 
pneumoniae, S. aureus and E. faecalis) were inoculated in 5 ml MH broth and incubated 
overnight at 37 C in a water bath with an orbital shaker. The absorbance of overnight 
bacterial cultures were read using a UV-visible spectrophotometer (Varian Cary 50, 
Australia) at 600 nm and the cultures were diluted with MH broth to a final inoculum of 
approximately of 10
6
 cfu/ml (colony forming units). One hundred microliters of the 
resuspended plant extracts (10 mg/ml) were two-fold serially diluted with distilled water to 
make up concentrations ranging from 2.5-0.02 mg/ml, in triplicates, down a 96-well micro-
plate (Greiner Bio-one, Germany). A two-fold serial dilution of neomycin (0.1 mg/ml) was 
used as a positive control against each test bacterial strain. Sterile MH broth, distilled water 
and 20% DMSO were used as the negative controls. The plates were then covered with 
parafilm and incubated overnight at 37 C. Growth of bacteria was detected by adding 50 µl of 
0.2 mg/ml p-iodonitrotetrazolium chloride (INT) to each well and the plates were further 
incubated for 1 h at 37 C. Bacterial growth was indicated by a red-pink colour, whereas clear 
wells indicated inhibition of bacterial growth by the test plant extract. Minimum inhibitory 
concentration (MIC) values were recorded as the lowest concentration of the extract showing 
a clear well. The assay was done twice; also in triplicates to confirm results. Plant extracts 
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with MIC values lower than 1 mg/mg were considered to have noteworthy antibacterial 
activity (Eloff, 1998). 
 
2.4. Antifungal assay  
2.4.1. Fungal stock preparation  
Candida albicans (ATCC 10231) bought from the African Bureau of Standards was used in 
the present study. One hundred microlitres of the fungal stock kept in a -70°C freezer was 
inoculated in 5 ml Yeast Malt broth (YM) and incubated overnight at 37°C. The overnight 
culture was streaked onto a Petri dish with solidified yeast malt agar and incubated further 
overnight at 37°C. The resulting agar culture plates were stored in the refrigerator at 4°C. 
 
2.4.2. Microdilution bioassay 
The antifungal activity of the assessed Croton species was determined by following the 
micro-dilution assay as previously described (Eloff (1998)) and modified for fungi by 
Masoko et al. (2007). The fungal cultures growing on YM agar plates (20 ml) was inoculated 
in 5 ml of YM broth and incubated in a shaker at 37°C overnight. Four hundred microliters of 
the overnight C. albicans culture was added to 4 ml of sterile saline (0.85% NaCl). The 
absorbance was read at 530 nm. The McFarland standard culture solution of 0.5 M (ranging 
from 0.2500-0.2800) was obtained and adjusted by adding sterile saline. The standardised 
fungal solution was further diluted with sterile YM broth making a 1:1000 dilution. The plant 
extracts were resuspended in 20% DMSO at a concentration of 50 mg/ml. In a 96-well micro-
plate (Greiner Labortechnik) each resuspended extract was two-fold serially diluted with 
sterile distilled water to make up concentrations ranging from 12.5-0.098 mg/ml in the wells. 
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A similar two-fold dilution was done with Amphotericin B (0.25 mg/ml) as a positive control. 
Water, DMSO (20%), and sterile YM were used as the negative controls. One hundred 
microliters of the diluted fungal culture were added to each well. The plates were covered 
with parafilm and incubated at 37°C for 24 h. To obtain MIC values, 50 µl of INT (0.2 
mg/ml) were added to each well and further incubated for 24 h. Wells that remained clear 
indicated that there was inhibition of fungal growth, while a red-pink colour in the wells 
indicated the growth of C. albicans. The MIC was recorded as the lowest concentration 
where there was no fungal growth. Here MIC<1 mg/ml were considered noteworthy. The 
experiment was repeated twice and was done in triplicates.
2.5. Results and discussion 
Antimicrobial activity results of 160 extracts from six Croton species is presented in Table 
2.2. Here not all plant organs were collected for all plants, thus only 160 extracts. The 
efficacy of the extracts was measured as the MIC. This is the lowest concentration at which 
microbial growth is inhibited by the extract. Minimum inhibitory concentrations less than 1 
mg/ml were considered as noteworthy for both antibacterial and antifungal activity (Eloff, 
1998, Katerere and Eloff, 2008).  
There has been previous scientific research conducted to validate the use of C. gratissimus in 
traditional medicine. In a study conducted by Van Vuuren and Naidoo (2010), essential oils 
extracted from C. gratissimus leaves displayed noteworthy inhibitory activity against 
Neisseria gonorrhoeae and Gardnerella vaginalis, two bacterial species associated with 
Sexually Transmitted Infections (STI‘s). These findings are significant as C. gratissimus is 
traditionally used to treat STI‘s and wounds associated with them (Van Wyk and Gericke, 
2000, Koenen, 2001, Van Vuuren and Viljoen, 2008). Therefore its use has been validated.  
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In the current study all C. gratissimus organs displayed noteworthy antibacterial activities, 
except for twig and stem bark extracts (C. gratissimus) from plants collected at Muden. C. 
gratissimus from the Durban Botanic Gardens and Southport had more extracts with 
noteworthy inhibitory activity in their organs compared to other samples of the same species. 
The noteworthy activities were only for two of the tested bacterial species; these were S. 
aureus and E. faecalis. These leaf extracts displayed noteworthy antibacterial activities 
against two Gram-positive bacterial strains namely S. aureus and E. faecalis, and a Gram-
negative strain (K. pneumoniae) with MIC values ranging from 0.16-0.63 mg/ml. They were 
the only leaf extracts to demonstrate noteworthy antibacterial activities against S. aureus 
(MIC 0.16-0.24 mg/ml) and K. pneumoniae (MIC = 0.63 mg/ml) within the species C. 
gratissimus. The most effective C. gratissimus extracts were the Durban Botanic Gardens 
DCM and PE leaf extracts with MIC values of 0.24 and 0.16 mg/ml, respectively. Generally, 
DCM and PE extracts of leaf samples collected in Durban Botanic Gardens, Southport and 
Muden demonstrated noteworthy antibacterial activities against E. faecalis (MIC range: 0.31-
0.94 mg/ml).  
Extracts from twigs collected from Southport yielded noteworthy antibacterial activities 
against three of the four evaluated bacterial strains, while those from the Durban Botanic 
Gardens displayed noteworthy activities only against E. faecalis and S. aureus. Twigs from 
Muden yielded MIC ≥1.25 mg/ml. Some of the extracts of C. gratissimus stem bark collected 
at the Durban Botanic Gardens and Southport yielded noteworthy antibacterial properties 
(MIC range: 0.31-0.94 mg/ml), while those collected in Muden did not show noteworthy 
antibacterial properties (MIC ≥ 1.25 mg/ml). 
Leaves of C. sylvaticus from Vernon Crookes Nature Reserve and Ntunjambili demonstrated 
extended-spectrum antibacterial activities with MIC ranging from 0.24-0.94 mg/ml. 
However, leaf extracts from Southport demonstrated noteworthy activities against only one of 
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the evaluated bacterial strains (E. faecalis, MIC=0.63 mg/ml). Both organic and aqueous 
solvent extracts of leaves collected from Umdoni Park yielded MIC values ≥ 1.25 mg/ ml. 
C. sylvaticus twig extracts (Umdoni Park) demonstrated noteworthy antibacterial activities 
against three of the four tested bacterial strains (MIC range 0.31-0.94 mg/ml). However, 
extracts of twigs of the same plant species collected from Southport were effective only 
against E. faecalis and S. aureus (MIC 0.31-0.94 mg/ml). Twigs (PE extracts) collected from 
Ntunjambili displayed noteworthy bacteriostatic activities only against E. faecalis (MIC = 
0.63 mg/ml).  
Variations in antibacterial activities were also noticed in C. sylvaticus bark extracts from 
different locations within KZN. The organic solvent extracts of the stem bark from Umdoni 
Park yielded MIC values ranging from 0.31-0.94 mg/ml against two of the tested bacterial 
strains. However, both organic and aqueous solvent extracts from bark (C. sylvaticus) sample 
collected from Vernon Crookes Nature Reserve yielded MIC value ≥ 2.5 mg/ml. 
Generally the most noteworthy inhibitory activity was observed in C. sylvaticus from 
Umdoni Park, which also showed a broad spectrum of activity in its DCM and PE twig 
extracts with MIC ranging between 0.31-0.94 mg/ml. A similarity was observed between this 
range and that of DCM and PE twig extracts of C. sylvaticus collected in Southport which 
was also 0.31-0.94 mg/ml, however this was only for two species of bacteria (S. aureus and 
E. faecalis). This may suggest that the principal biological active compounds responsible for 
inhibiting S. aureus and E. faecalis are similar for C. sylvaticus and are soluble in DCM and 
PE. Within this species the most effective extract was the DCM leaf extract collected in 
Vernon Crookes Nature Reserve 0.24 mg/ml against E. faecalis.  
C. steenkampianus had two representative samples collected from the Durban Botanic 
Gardens and Kosi Bay. Only leaf and twig extracts of the plant species showed antibacterial 
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activity. Leaf extracts of C. steenkampianus collected at the Durban Botanic Gardens had the 
highest inhibitory activity with MIC ranging between 0.04-0.94 mg/ml. Leaf extracts of C. 
steenkampianus from Kosi Bay displayed noteworthy activities only against S. aureus (MIC 
range: 0.63-0.94 mg/ml).  
Organic solvent extracts from the twigs of C. steenkampianus (Durban Botanic Gardens) 
yielded noteworthy activities against S. aureus and E. faecalis, while twigs of the same plant 
species collected in Kosi Bay yielded MIC values ranging from 0.47-0.63 mg/ml against E. 
faecalis. 
The most effective C. steenkampianus sample was DCM leaf extract from the Durban 
Botanic Gardens (MIC=0.04 mg/ml) effective against E. faecalis. The most susceptible 
bacterial strain to C. steenkampianus was the Gram-positive S. aureus followed by Gram-
positive E. faecalis. Only one DCM leaf extract was effective against Gram-negative K. 
pneumoniae. In a study conducted by Selowa et al. (2010) C. steenkampianus did not show 
any antimicrobial activity. This may be due to a number of factors such as the differences in 
the duration of extraction and the concentration of the solvent used. 
C. pseudopulchellus leaf samples collected from Mkuze and Durban Botanic Gardens 
demonstrated noteworthy to potent antibacterial activities (MIC range: 0.08-0.94 mg/ml) 
against S. aureus and E. faecalis. Twig samples of the plant collected in Durban Botanic 
Gardens, Mkuze and Southport also demonstrated noteworthy antibacterial properties against 
the afore-mentioned bacterial strains (MIC range: 0.08-0.94 mg/ml). Extracts of the plant‘s 
stem bark collected from the Durban Botanic Gardens demonstrated better antibacterial 
properties (MIC range: 0.04-0.63 mg/ml) than bark samples of the same plant collected in 
Mkuze (MIC≥1.25 mg/ml). 
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C. pseudopulchellus showed the highest inhibitory activity in its stem bark extracts, 
compared to the stem bark extracts of the other species (MIC range: 0.04-0.94 mg/ml), this 
was followed by the stem bark extracts of C. menyhartii (MIC range:0.16 0.94 mg/ml). This 
validates the traditional use of these two species‘ bark in treating chest related infections, 
which may be caused by bacterial strains. Unlike other Croton species in addition to DCM 
and PE there were more methanol extracts that showed inhibitory activity from C. 
pseudopulchellus. This suggested that in addition to the DCM and PE soluble bioactive 
compounds possessed by C. pseudopulchellus there are other bioactive compounds that are 
soluble in methanol. This also suggests that Croton species may not all have the same 
chemical compounds and therefore may not all be used to treat the same ailments. A 
similarity in the inhibitory pattern of the leaf and twig MeOH, DCM and PE extracts against 
S. aureus and E. faecalis was observed. 
C. menyhartii showed limited inhibitory activity in its extracts. The DCM stem bark of 
C. menyhartii collected at Mkuze showed the best MIC of 0.16 mg/ml. There was a clear 
difference in the inhibitory activity between the leaf extracts of this species collected in 
Mkuze and Kranskop. Leaves collected from Mkuze were active against S. aureus and E. 
faecalis (MIC: 0.63-0.94 mg/ml), while those collected from Kranskop were not active 
against any of the four evaluated bacterial strains. This is not what should be expected from 
specimens of the same species, however the difference in environmental stresses experienced 
by members of the same species in different regions may lead to the production or lack of 
certain biological active compounds. This may also explain why traditional healers are 
specific to the location where they collect their medicinal plants. 
Twigs from Mkuze were active against both S. aureus and E. faecalis (MIC=0.63 mg/ml), 
while those from Kranskop demonstrated antibacterial activity only against S. aureus. 
(MIC=0.47 mg/ml).  
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There was only one collection of C. rivularis; which was from Umzimkhulu Valley. Extracts 
from this plant did not show any noteworthy activity. Conclusive information and a clear 
understanding to this could not be derived as there was one sample and no stem bark, which 
could have been the sample to show inhibitory activity. 
Overall twig extracts generally demonstrated broad-spectrum antibacterial activities yielding 
MIC values ranging from 0.16-0.94 mg/ml. However, the highest inhibitory activity was 
observed in the DCM extract of C. steenkampianus leaf extract from the Durban Botanic 
Gardens against E. faecalis (0.04 mg/ml). PE extract of C. pseudopulchellus stem bark also 
from Durban Botanic Gardens showed similar inhibitory activity (0.04 mg/ml) against E. 
faecalis. The majority of the noteworthy antibacterial activities were observed in DCM 
extracts (Table 2.2). The results showed E. faecalis to be the most susceptible bacterial strain 
followed by S. aureus. This is no surprise as it has become a common occurrence to witness 
Gram-positive microorganisms showing more susceptibility to plants antibacterial extracts 
than Gram-negative microorganisms (Fischbach and Walsh, 2009, Joshi et al., 2011). On 
the other hand, none of the plant extracts yielded any noteworthy inhibitory activity against 
E. coli. Only a few showed noteworthy inhibitory activity against K. pneumoniae, which are 
both Gram-negative bacteria. The resistance of gram-negative bacteria is attributed to the 
presence of an outer membrane which is made up of a lipopolysaccharide layer proteins and 
phospholipids. This membrane blocks the entry of substances into the bacteria. Therefore 
antibiotics cannot easily affect the organism (Kumar et al., 2006, Fischbach and Walsh, 
2009). The capability of Croton species to inhibit Gram-negative bacteria was demonstrated 
in a study by Van Vuuren and Viljoen (2008), where C. gratissimus leaf extracts exhibited 
the highest noteworthy inhibitory activity against three Gram-negative bacteria 
(Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumonia) compared to the 
bark and roots of the same species. This highlighted the efficacy of leaf extracts. 
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There were a number of extracts that did not show noteworthy antibacterial activities. These 
included all the water extracts, the leaf and twig extracts of C. rivularis collected in 
Umzimkhulu Valley, which was the only sample of the species that was collected (due to the 
lack of known localities around KZN), and therefore there could not be compared with 
members of the same species collected in different regions. Water extracts have generally 
exhibited no inhibitory activity in antimicrobial studies of plants (Lewu et al., 2006, Fawole, 
2009). The water extracts in this study were not prepared in the exact way that traditional 
healers prepare their medicinal plants which involved boiling a medicinal plant for several 
hours or mixing and boiling two of more medicinal plants. This explains the inability to 
detect inhibitory activity of the aqueous extracts (Clarkson et al., 2004).  
Only one extract yielded noteworthy activity against C. albicans. This was from the MeoH 
leaf extracts of C steenkampianus collected at Kosi Bay, with the MIC value of 0.6 mg/ml. 
 
2.6. Conclusions 
Croton species are already known for their ethnomedicinal importance and some of the 
species have been subjected to phytochemical studies to validate their use (Van Vuuren and 
Viljoen, 2008, Selowa et al., 2010, Van Vuuren and Naidoo, 2010), however the 
knowledge of the increased threat caused by large scale harvesting and trading of medicinal 
plants in South Africa (Lewu et al., 2006, Shai et al., 2009) prompted the necessity to 
conduct further comparative investigations. These were to gather information that would 
assist in improving sustainability of Croton species. This would be achieved through 
identifying and exploring possibilities of substitution across the species and plant organs. 
There was no similar pattern in the inhibitory activity between samples of the same species 
collected from different regions. This may support the claim made by Ndhlala et al. (2013) 
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that geographic distribution has an influence in the chemical composition of plant species, 
thus the variations in antibacterial properties. Different environmental stresses are known to 
trigger the production of specific secondary metabolites in plants required for their survival, 
thus the variation in biochemical activities (Mwine and Van Damme, 2011). These 
environmental stresses may include altitude, climate, soil composition and harvesting time 
(Atanasov et al., 2015).  
A total of 107 extracts showed noteworthy inhibitory activities (MIC<1 mg/ml) against the 
test bacterial strains. Figure 2.1 shows the percentages of the noteworthy activity from the 
different plant organs, of which twigs had the most noteworthy activity (44%) compared to 
the other organs. The stem bark had the lowest percent of noteworthy inhibitory activity 
(17%) and the leaves 39%. These results demonstrate that it is possible to substitute leaves 
and twigs for stem bark. Other studies by Lewu et al. (2006), Van Vuuren and Viljoen 
(2008), and Van Vuuren and Naidoo (2010) have shown results of aerial plant organs such 
as leaves and twigs exhibiting higher antibacterial activity compared to the bark or roots.  This 
further suggests that the leaves and twigs are possibly more effective than the bark and that the 
leaves and twigs should rather be used in treatment of ailments.  
There was no significant antifungal activity demonstrated by all the extracts with the 
exception of the MeoH leaf extracts of C. steenkampianus collected from Kosi Bay. This was 
the only extract that showed noteworthy inhibitory against fungi with MIC value of 
0.6 mg/ml.  
The plants evaluated in the current study were all from the same genus (Croton) and are 
mostly used to treat similar ailments (Table 1.1), however they did not yield the same 
antimicrobial activity, and this could be due to variation in concentration of the bioactive 
chemical compounds contained by the different plants. Plants extracts that exhibited lower or 
   
 32  
 
no inhibitory activity may not be suitable candidates for pharmaceutical production and use 
(Rabe and Van Staden, 1997). Previous studies have reported noteworthy activity of 
essential oil extracted from Croton species (Martins et al., 2000, Alviano et al., 2005, Van 
Vuuren and Viljoen, 2008). It may be worthwhile to explore this approach in future for the 
species in this study. 
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Table 2.2: Antibacterial and antifungal activity (Minimum inhibitory concentration, MIC) of different plant organs of Croton species collected 
within KwaZulu-Natal, South Africa. 
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/ml) 
   
Bacteria Fungi 
   
E. c. S. a. E. f. K. p. C.a. 
C. gratissimus Southport Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 2.5 0.31 1.25 >12.5 
  
DCM 2.5 2.5 0.31 >2.5 6.3 
  
PE 2.5 2.5 1.25 >2.5 >12.5 
 
Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 2.5 2.5 2.5 >12.5 
  
DCM >2.5 0.63 0.63 0.47 6.3 
  
PE >2.5 0.63 0.63 0.63 >12.5 
 
Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 2.5 >2.5 >2.5 >12.5 
  
DCM 2.5 0.31 0.31 2.5 >12.5 
  
PE >2.5 0.63 0.63 >2.5 >12.5 
C. gratissimus D.B.G. Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 1.25 2.5 2.5 >12.5 
  
DCM 2.5 0.24 0.31 0.63 6.3 
  
PE >2.5 0.16 0.63 >2.5 6.3 
 
Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 0.47 >2.5 >2.5 >12.5 
  
DCM 2.5 0.24 0.63 2.5 6.3 
  
PE >2.5 0.31 1.25 >2.5 >12.5 
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Table 2.2 continued… 
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/ml) 
   Bacteria Fungi 
   E. c. S. a. E. f. K. p. C.a. 
 
Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 2.5 >2.5 >2.5 >12.5 
  
DCM >2.5 0.63 0.94 1.9 >12.5 
  
PE >2.5 1.25 2.5 >2.5 >12.5 
C. gratissimus Muden Leaves Water >2.5 >2.5 2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 2.5 >2.5 1.6 
  
DCM >2.5 1.25 0.63 >2.5 3.1 
  
PE >2.5 2.5 0.94 >2.5 9.4 
 
Twigs Water >2.5 >2.5 2.5 >2.5 >12.5 
  
MeOH >2.5 2.5 >2.5 >2.5 >12.5 
  
DCM >2.5 1.25 1.25 >2.5 >12.5 
  
PE >2.5 1.25 1.9 >2.5 >12.5 
 
Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 1.25 2.5 2.5 >12.5 
  
DCM >2.5 2.5 1.25 >2.5 >12.5 
  
PE >2.5 2.5 >2.5 >2.5 >12.5 
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Table 2.2 continued… 
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/m l) 
   Bacteria Fungi 
   E. c. S. a. E. f. K. p. C.a. 
C. sylvaticus Southport Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 2.5 2.5 12.5 
  
DCM 2.5 2.5 0.63 >2.5 6.3 
  
PE >2.5 2.5 1.9 >2.5 6.3 
 
Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  
DCM 2.5 0.31 0.94 2.5 6.3 
  
PE >2.5 0.31 0.63 >2.5 >12.5 
C. sylvaticus Umdoni Park Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 2.5 2.5 >2.5 6.3 
  DCM >2.5 2.5 1.25 2.5 6.3 
  PE >2.5 1.25 1.25 2.5 12.5 
 Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 1.25 >2.5 0.63 >12.5 
  DCM >2.5 0.63 0.94 0.31 >12.5 
  PE 2.5 0.63 0.63 0.63 >12.5 
 Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 0.94 >2.5 0.63 >12.5 
  DCM >2.5 0.31 1.25 >2.5 >12.5 
  PE 2.5 0.63 1.25 >2.5 6.3 
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Table 2.2 continued… 
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/ml) 
   Bacteria Fungi 
   E. c. S. a. E. f. K. p. C.a. 
C. sylvaticus Ntunjambili Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH 2.5 2.5 0.63 2.5 9.4 
  
DCM 2.5 0.94 0.47 0.94 4.7 
  
PE 2.5 1.25 0.31 2.5 >12.5 
 
Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  
DCM >2.5 >2.5 >2.5 >2.5 6.3 
  
PE >2.5 1.25 0.63 1.9 >12.5 
C. sylvaticus Vernon Crookes N.R. Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 >2.5 1.25 >2.5 >12.5 
  DCM 1.25 1.25 >0.24 0.63 >12.5 
  PE 2.5 0.63 0.63 0.63 >3.1 
 Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 2.5 >2.5 >2.5 >12.5 
  DCM >2.5 0.63 1.25 2.5 6.3 
  PE >2.5 0.63 0.31 >2.5 >12.5 
 Stem Bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  DCM >2.5 2.5 2.5 2.5 >12.5 
  PE >2.5 >2.5 >2.5 >2.5 >12.5 
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Table 2.2 continued… 
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) 
Antifungal MIC 
(mg/ml) 
   Bacteria Fungi 
   E. c. S. a. E. f. K. p. C.a. 
C. steenkampianus D.B.G. Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH 2.5 0.47 0.31 1.25 3.1 
  
DCM 1.9 0.31 0.04 0.94 3.1 
  
PE >2.5 1.25 0.94 >2.5 >12.5 
 
Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 0.63 >2.5 >2.5 >12.5 
  
DCM 2.5 0.31 0.47 1.9 >12.5 
  
PE >2.5 1.25 0.63 >2.5 >12.5 
 
Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  
DCM 2.5 1.9 2.5 2.5 >12.5 
  
PE >2.5 >2.5 1.25 >2.5 >12.5 
C. steenkampianus Kosi Bay Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 2.5 >2.5 >2.5 0.6 
  
DCM >2.5 0.94 >2.5 1.25 1.17 
  
PE >2.5 0.63 2.5 1.9 3.1 
 Twigs Water >2.5 >2.5 2.5 >2.5 >12.5 
  MeOH >2.5 0.63 >2.5 >2.5 >12.5 
  DCM 2.5 0.47 1.25 1.9 >12.5 
  PE >2.5 1.25 1.25 >2.5 >12.5 
 Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 2.5 >2.5 >2.5 >12.5 
  DCM >2.5 1.25 1.25 >2.5 >12.5 
  PE >2.5 1.25 1.25 >2.5 3.1 
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Table 2.2 continued…  
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/ml) 
   Bacteria Fungi 
   E. c. S. a. E. f. K. p. C.a. 
C. pseudopulchellus D. B. G. Leaves Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH  0.31 0.94 >2.5 >12.5 
  DCM 2.5 0.12 0.16 2.5 3.1 
  PE >2.5 0.12 0.16 >2.5 >12.5 
 Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 0.31 2.5 >2.5 >12.5 
  DCM >2.5 0.31 0.63 >2.5 >12.5 
  PE >2.5 0.16 0.63 >2.5 >12.5 
 Stem Bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 0.63 >2.5 >2.5 >12.5 
  DCM >2.5 0.08 0.63 >2.5 >12.5 
  PE >2.5 0.63 0.04 >2.5 >12.5 
C. pseudopulchellus Mkuze Leaves Water >2.5 2.5 >2.5 >2.5 >12.5 
  MeOH 2.5 0.31 1.9 2.5 >12.5 
  DCM 2.5 0.08 0.31 2.5 6.3 
  PE >2.5 0.31 0.94 >2.5 12.5 
 
Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 0.47 1.25 >2.5 >12.5 
  
DCM >2.5 0.31 0.94 >2.5 >12.5 
  
PE >2.5 0.47 0.94 >2.5 >12.5 
 
Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 1.25 >2.5 >2.5 >12.5 
  
DCM >2.5 >2.5 >2.5 >2.5 >12.5 
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Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/ml) 
   Bacteria Fungi 
   E. c. S. a. E. f. K. p. C.a. 
  
PE >2.5 >2.5 >2.5 >2.5 >12.5 
C. pseudopulchellus Southport Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 0.31 0.63 >2.5 >12.5 
  
DCM >2.5 0.12 0.31 >2.5 >12.5 
  
PE >2.5 0.08 0.31 >2.5 >12.5 
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Table 2.2 continued… 
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/ml) 
   Bacteria Fungi 
   E. c. S. a. E. f. K. p. C.a. 
C. menyhartii Mkuze Leaves Water >2.5 >2.5 2.5 >2.5 >12.5 
  
MeOH >2.5 2.5 >2.5 >2.5 6,3 
  
DCM 2.5 0.94 0.94 2.5 >12.5 
  
PE >2.5 0.63 >2.5 >2.5 4,7 
 
Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  
DCM >2.5 0.63 1.25 >2.5 >12.5 
  
PE >2.5 0.63 0.63 >2.5 >12.5 
 
Stem bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  
DCM >2.5 0.16 2.5 2.5 >12.5 
  
PE >2.5 0.63 0.63 >2.5 >12.5 
C. menyhartii Kranskop Leaves Water >2.5 >2.5 2.5 >2.5 >12.5 
  MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  DCM >2.5 2.5 1.9 1.9 6,3 
  PE >2.5 >2.5 2.5 2.5 >12.5 
 Twigs Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 2.5 >2.5 >2.5 >12.5 
  DCM >2.5 0.47 2.5 2.5 12,5 
  PE >2.5 0.47 2.5 2.5 12,5 
 Stem Bark Water >2.5 >2.5 >2.5 >2.5 >12.5 
  MeOH >2.5 2.5 >2.5 >2.5 >12.5 
  DCM >2.5 0.94 0.63 >2.5 >12.5 
  PE >2.5 0.94 1.9 >2.5 >12.5 
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Table 2.2 continued… 
Species and locality Plant part Solvent Antibacterial MIC (mg/ml) Antifungal MIC (mg/ml) 
  
 Bacteria Fungi 
  
 E. c. S. a. E. f. K. p. C.a. 
C. rivularis Umzimkhulu Valley Leaves Water >2.5 >2.5 2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 2.5 >2.5 >12.5 
  
DCM 2.5 2.5 >2.5 2.5 9,4 
  
PE >2.5 >2.5 >2.5 >2.5 >12.5 
 
Twigs Water >2.5 2.5 >2.5 >2.5 >12.5 
  
MeOH >2.5 >2.5 >2.5 >2.5 >12.5 
  
DCM >2.5 1.25 1.25 >2.5 >12.5 
  
PE 2.5 2.5 2.5 >2.5 6,3 
Neomycin (µg/ml) 
  
0.39 1.56 6.25 1.56 
 DMSO 10 % 
  
>2.5 >2.5 >2.5 >2.5 >12.5 
Amphotericin (µg/ml)       0.15 
MeOH=Methanol; DCM= Dichloromethane, PE= Petroleum ether, E.c=Escherichia coli, S.a= Staphylococcus. aureus, E.f= Enterococcus. 




   






3.1. Introduction  
The World Health Organisation has identified plants as one of the best possible natural 
sources of new therapeutic drugs (Nascimento et al., 2000). The use of phyto-medicines 
dates back to time immemorial. This is evident in the available successful drugs and 
medicines made from plant derivatives (Savithramma et al., 2011). Recent reports suggest 
that plant-derived drugs contribute about 25% of the globally prescribed drugs (Rates, 2001, 
Amoo et al., 2011). The concentration and availability of bioactive phyto-compounds often 
differ from one plant species to the other, as well as organs of the same plant species, 
(Savithramma et al., 2011). This is evident in the therapeutic activity of different plant 
groups and species (Briskin, 2000). Similarly a single plant or plant organ may contain a 
great variety of bioactive compounds rendering it of considerable pharmacological 
importance, for this reason it is has been advised to screen plants for a variety of biological 
active compounds and activities (Houghton et al., 2005, Amoo et al., 2011). In this study 
methanolic extracts of six Croton species and their organs were evaluated for the presence 
and quantity of a series of phytochemicals. There was great variation observed in the 
antimicrobial activities of the different Croton species and their different organs. A study of 
the phytochemical composition of the species would give better understanding of the 
outcomes the antimicrobial tests done in the previous chapter. 
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3.2. Phytochemical profiling of selected medicinal plants 
Plants defend themselves form herbivores, insects and microorganisms by producing a great 
variety of bioactive, secondary metabolites (Savithramma et al., 2011).The ability of these 
compounds to either kill or inhibit the growth of pathogens, while inflicting little to no harm 
to humans or other hosts qualify phyto-compounds as perfect candidates for antimicrobial 
drug development (Ahmad and Beg, 2001). 
Some of the most important bioactive phytochemicals include flavonoids, tannins, alkaloids 
and phenolics (Edeoga et al., 2005). As medicinal plants continue to captivate the attention 
of scientists around the world, research efforts have been primarily targeted at elucidating the 
phytochemical and pharmacological properties of these valued natural resources. In a general, 
phytochemical studies involve chemical profiling of different parts of medicinal plants as 
well as the characterisation and identification of principal bioactive phyto-compounds. On the 
other hand, pharmacological research is also directed towards screening organic solvent, as 
well as aqueous medicinal plant extracts for pharmacological properties. Such studies may 
also entail elucidating the mode of action of bioactive phyto-compounds (Briskin, 2000, 
Aremu et al., 2011). Phytochemical and pharmacological research is necessary in attaining 
information useful in developing novel therapeutic drugs (Yadav and Agarwala, 2011). 
 
3.3. Secondary metabolites  
Secondary metabolites are chemical compounds synthesized by plants and appear to have no 
designated roles in maintaining essential life processes such as plant growth and 
development. They have, however, been shown to have a significant role in the interaction of 
plants and their environment (Bennett and Wallsgrove, 1994, Bourgaud et al., 2001, Afrin 
et al., 2015). Thus, the evolution and production of secondary metabolites is a response to the 
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challenges exerted on plants by their natural environment (Demain, 1999). They are 
synthesized in small amounts, usually less than 1 % in dry weight (Bourgaud et al., 2001, 
Shakeri et al., 2012). This is also dependent on the growth stage, environmental conditions 
and physiology of the plant (Bourgaud et al., 2001). Studies have shown plant secondary 
metabolites to be active antibacterial, antifungal, anti-carcinogenic, anti-mutagenic, anti-
inflammatory, anti-oxidant, anti-diabetic and anti-tumour agents (Moyo et al., 2010, Somit et 
al., 2013). Many medicinally valued plants owe their antimicrobial characters to the various 
compounds produced during secondary metabolism in plants (Briskin, 2000, Nascimento et 
al., 2000). These antimicrobial and therapeutic characters of plants may not often be ascribed 
to a single metabolite but may be a result of a combination of different secondary metabolites 
(Ncube et al., 2008, Joshi et al., 2011).  
 
3.3.1. Tannins 
Bate-Smith and Swain (1962) defined tannins as a group of water soluble phenolic 
compounds capable of turning animal hides into leather. Tannins are mostly found in vascular 
plants, occurring in different plant parts such as seeds, leaves and flowers but, they 
predominantly occur in the woody tissues of the plants (Aremu, 2009). In plants, these 
polyphenols occur mainly as hydrolysable or non-hydrolysable tannins (Chung et al., 1998, 
Santos‐Buelga and Scalbert, 2000). As shown in Figure 3.1, hydrolysable tannins are 
characterised by having a central carbohydrate molecule to which several hydroxyl groups 
and/or other functional groups are attached (Mueller-Harvey, 2001). Different types of 
tannins are formed when these functional groups react and join with other compounds. For 
instance, the esterification of gallic acid and polyol carbohydrates give rise to gallotannins, 
while ellagitannins are formed by the oxidative linkage of polyhydralic alcohols and ellagic 
acid (Niemetz and Gross, 2005). 













































beta-D-Glucose pentakis(3,4-dihydroxy-5-((3,4,5-trihydroxybenzoyl)oxy)benzoate)  
Figure 3.1.Chemical structure of tannic acid showing a central ß- D glucose molecule 
surrounded by several functional groups (Cowan, 1999). 
Non-hydrolysed tannins (or condensed tannins) are structurally more complex than 
hydrolysable tannins and are mainly formed as a result of condensation reactions of 
benzopyran derivatives commonly known as flavans (Cowan, 1999, Xie et al., 2003). 
Flavan-3-ols and flavan-3,4-diols form tannin oligomers and polymers either individually or 
in combinations (Haslam, 2007, Aron and Kennedy, 2008). Condensed tannins are also 
referred to as proanthocyanidins since they depolymerize and yield red anthocyanidins upon 
heating in acidic solutions (Schofield et al., 2001). This chemical property forms the basis of 
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the colorimetric analysis technique popularly known as the acid-butanol assay (Gessner and 
Steiner, 2005). 
Although implicated in poor protein digestibility, reduced energy metabolism and feed intake 
in livestock (Chung et al., 1998, Min et al., 2003), tannins have tremendous human health 
benefits due particularly to their outstanding astringent properties (Manach et al., 2004). 
Carcinogens and mutagens produce oxygen free radicals capable of interacting with several 
cellular components often leading to mutations and cancerous growths in animals (Valko et 
al., 2006). However, polar hydroxyl groups in tannins readily complex with paramagnetic 
hyperoxide radicals and hence protect cellular components from oxidative damages 
(Zielińska-Przyjemska et al., 2015). Tannic acid has also be shown to inhibit the generation 
of superoxide radicals in some animal tissues (Gülçin et al., 2010). These properties perhaps 
explain why tannins have, of late, been extensively investigated as potential anticarcinogens 
and antimutagens.  
The antibacterial activities of tannins are well documented. Several researchers have 
demonstrated that some pathogenic Gram-negative and -positive bacterial strains are 
susceptible to the tannins (Chung et al., 1993, Mustapha et al., 2017, Steiner et al., 2017, 
Yang et al., 2017, Dong et al., 2018). These polyphenols chelate nutrients and ions from 
bacterial growth media making them less available to bacteria (Mila and Scalbert, 1993, 
Chung et al., 1998). They also inhibit enzyme catalysed reactions by either binding to 
enzymes or their substrates (Akiyama et al., 2001). Tannins have also been shown to be 
responsible for antifungal, antioxidant anti-inflammatory and many healing properties 
exhibited by some medicinal plant extracts (Moyo et al., 2010). 
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Other pharmacological activities associated with tannins include accelerated blood clotting, 
modulation of immune responses and reduced blood pressure (Okuda, 1995, Chung et al., 
1998).  
 
3.3.2. Flavonoids  
The term flavonoid is derived from the Latin term flavus which means yellow (Cotelle, 
2001). Flavonoids (some of which are yellow in colour) are a large group of structurally 
diverse secondary metabolites found in ferns, bryophytes, algae, angiosperms and 
gymnosperms (Iwashina, 2000). Over 9 000 flavonoids are found in the plant kingdom 
(Wang et al., 2011), and are based on their chemical properties, which can be subdivided 
into 15 classes including anthocyanins, flavones, flavonols, flavanones, flavan, 
proanthocyanidins, isoflavonoids, bioflavonoids, etc. (Yao et al., 2004). Despite their 
manifold chemical diversity, all flavonoids are made up of a 15 carbon skeleton consisting of 
two aromatic rings (A and B) and one heterocyclic ring (C) (Cushnie and Lamb, 2005) as 
depicted in Figure 3.2. Numerous structurally diverse flavonoid compounds are formed by 
the addition of hydroxyl, methoxyl, methyl, glycosyl, sulafate, prenyl and isoprenyl, aromatic 
or aliphatic groups to the flavonoid carbon skeleton (Iwashina, 2000, Kumar and Pandey, 
2013). Generally, the presence of hydroxyl groups and sugars makes flavonoids hydrophilic 
whereas prenyl units and methyl groups makes them lipophilic in nature (Chebil et al., 
2007). Apart from preventing microbial invasions, flavonoids are also involved in several 
other unrelated plant functions such as nitrogen fixation, ultra-violet filtration, chemotropism, 
cell cycle inhibition as well as floral, foliage and fruit pigmentation (Woo et al., 2002).  
Flavonoids have in recent years attracted much interest from several research groups around 
the world due to their numerous pharmacological properties. Their anti-inflammatory, 
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analgesic, anticancer, anti-HIV, antimicrobial, and antioxidant activities are well documented 
(Lee et al., 2003, Yao et al., 2004, Ravishankar et al., 2013, Xiao et al., 2016) . They are 
believed to exert their antibacterial activity through forming complexes with bacterial 
extracellular materials and proteins as described for tannins above (Cowan, 1999). Lipophilic 
flavonoids, however, rupture cell membranes resulting in the leakage of cytoplasm and the 
subsequent death of bacterial cells (Taylor et al., 2005). Additional antibacterial mechanisms 
observed includes inhibition of cytoplasmic membrane formation, DNA gyrase and energy 
metabolism (Cushnie and Lamb, 2005). Catechins represent an interesting group of 
antibacterial flavonoids since they were demonstrated to inhibit the growth of Vibrio cholerae 
and to inactivate its toxins (Borris, 1996). Other studies revealed that catechin, inhibits the 
passage of hydrophilic molecules into bacteria cells (Nakayama et al., 2013), damage 
bacterial cell walls and prevent the formation of peptidoglycan (Taylor et al., 2005, 








Figure 3.2: Chemical structure of a flavonoid (kaempferol). Letters A and B denote aromatic 
rings, while C is a heterocyclic ring (Williams and Grayer, 2004). 
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3.3.3. Phenolic acids 
Phenolic acids form another group of plant based, pharmacologically important polyphenols. 
Two categorises of these phenolic compounds can be distinguished: hydrobenzoic and 
hydroxycinnamic acids (Dykes and Rooney, 2007). Hydrobenzoic acids are derivatives of 
benzoic acid and include gallic, p-hydrobenzoic, protocatechuic, syringic and vanillic acid 
(Manach et al., 2004). The chemical structure of gallic acid is shown in Figure 3.3. These 
phenolic acids occur abundantly in red fruits, black radish, onions and tea leaves (Shahidi 
and Naczk, 1995). It is worth noting that some hydrobenzoic acids often form components of 













Figure 3.3: Chemical structures of a hydroxybenzoic acid (A: gallic acid) and a 
hydroxycinnamic acid (B: caffeic acid) (Cowan, 1999).  
Hydroxycinnamic acids are derivatives of cinnamic acid made up of a 9 carbon skeleton 
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coumaric, ferulic and sinapic acids (Manach et al., 2004). The chemical structure of caffeic 
acid is shown in Figure 3.3. In plants, phenolic acids exist freely or bound to other 
compounds (Bonoli et al., 2004). Hydroxycinnamic acids exist mainly in the bound form as 
glycosylated derivatives or esters of quinic, shikimic and tartaric acid (Nardini et al., 2002, 
Buiarelli et al., 2010). Chlorogenic acid for example is formed by the combination of caffeic 
and quinic acids (Puupponen-Pimiä et al., 2005). 
Some phenolic acids are known to have potent antibacterial properties. Studies by Borges et 
al. (2013) revealed that gallic acid and ferulic acids exert their bactericidal effects by binding 
to and rupturing bacterial cell membranes. Lou et al. (2011) demonstrated that chlorogenic 
acid binds to some Gram-positive and Gram-negative bacterial strains and increase their 
permeability. This in turn caused the leakage of both cytoplasmic and nuclei material leading 
to bacterial cell death. P-coumaric acid also causes intracellular material leakages and 
interferes with bacterial DNA replication and gene expression (Lou et al., 2012). The activity 
of sinapic acid against a wide range of Gram-positive and Gram-negative bacterial strains 
was also demonstrated by several researchers (Nowak et al., 1992, Barber et al., 2000, 
Johnson et al., 2008). However, most lactic acid bacteria such as Lactobacillus plantarum 
are resistant to sinapic acid (Engels et al., 2012). This selective antibacterial activity suggests 
that sinapic acid can potentially be used to extend the shelf life of milk and its products. 
The type and concentration of pharmacologically important secondary metabolites differ 
from one medicinal plant species to the other and within organs of the same plant species. 
The current study was therefore designed to determine the concentrations of condensed 
tannins, flavonoids, phenolic acids and total phenolic content in aqueous methanol extracts 
from the six selected Croton species. In this study the phytochemical properties from the 
various Croton species and their different organs were compared.  




3.3.4. Alkaloids  
Alkaloids are defined as heterocyclic nitrogen containing compounds commonly derived 
from amino acids (Agostini-Costa et al., 2012, Perviz et al., 2016). Other closely related 
compounds that contain neutral or weak acid properties are also included as alkaloids 
(Kabera et al., 2014). All of these fall in one of the three different categories that alkaloids 
have been assigned to, which are based on the alkaloids‘ source or the initial substance of 
their biosynthetic pathway and physical structure (Bennett and Wallsgrove, 1994, Eguchi et 
al., 2019). These categories include; true alkaloids, these are synthesized by amino acids, 
have nitrogen in heterocyclic rings and are basic, examples are atropine and nicotine; 
protoalkaloids; these are also synthesized by amino acids and are basic, however their 
nitrogen is not in a heterocycle, an example is mescaline. The final category are the 
pseudoalkaloids; these are not synthesized by amino acids examples are solanidine and 
caffeine (Bennett and Wallsgrove, 1994). Alkaloids are produced by living organisms such 
as bacteria, fungi, animals and more commonly plants (Kabera et al., 2014, Perviz et al., 
2016). About 15% of these living organisms contain alkaloids and 12 000 has been identified 
in plants (Wink, 2003a). Many alkaloids are genus or species-specific (Bourgaud et al., 
2001). Many alkaloids may occur in any of plant organs but there are some that are organ-
specific (Cushnie et al., 2014, Othman et al., 2019).  
In plants, alkaloids are essential defence agents against pathogens and herbivores. Their 
potency has led to their prevalent use as pharmaceutical, narcotics, stimulants and poisons 
(Facchini and St-Pierre, 2005, Richard et al., 2013). They are furthermore recognised for 
their efficacious antimicrobial properties; inhibiting various bacterial and fungal pathogens 
(Shakeri et al., 2012, Marutescu et al., 2017). Pyrrolizidine alkaloids, quinolizidine alkaloid 
extracts, furoquinoline alkaloids and isoquinoline alkaloids are some of the prevalent 
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biologically active alkaloids (Marutescu et al., 2017). Alkaloids have a variety of 
mechanisms of action against microbes and these vary with different alkaloids. Some of them 
include inhibiting cell division of microbes, disruption of bacterial cell membranes, inhibition 
of virulence genes and inhibiting bacterial enzymes (Othman et al., 2019) Alkaloids are a 
structural (Cushnie et al., 2014) and chemically diverse group of compounds ranging, from 
the simple coniine compound to strychnine with a pentacyclic structure (Makkar et al., 
2007). Similarly alkaloids have a wide range of therapeutic functions in the medical sector 
this includes the analgesic codeine and morphine, the sedative scopolamine, muscle relaxants 
papaverine and (+) - tubocurarine, anti-cancerous vinblastine the anti-arrhythmic, ajmaline 
and the gout suppressant colchicine (Facchini and St-Pierre, 2005). Even with their wide 
clinical use some alkaloids are extremely toxic to humans, even in small quantities e.g. 
coniine and strychnine; other clinically used alkaloids are also toxic (Bush and Fannin, 
2009).  
 
3.3.5. Oxidative stress and antioxidant activity  
Oxidative stress is a result of increased production of free radicals in the human body. This is 
due to the imbalance and low production of antioxidants by the cells (Pham-Huy et al., 
2008, Aremu et al., 2011). Free radicals are described as unstable molecules that contain 
unpaired electrons on their outer shell. Their unpaired electrons are highly reactive, reacting 
with and altering organic molecules in an organism‘s body such as lipids, DNA and proteins 
(Pham-Huy et al., 2008) therefore triggering various human diseases (Lobo et al., 2010). 
Free radicals or reactive oxygenic species (ROS) produced as by-products of the human 
body‘s metabolism (Amarowicz et al., 2004) are known to cause damage to cells, tissues and 
organs (Gupta and Sharma, 2006, Prasad et al., 2010). These radicals have been implicated 
in the occurrence of many diseases in humans (Amoo et al., 2011, Aremu et al., 2011), such 
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as inflammation , cardiovascular diseases, diabetes and cancer (Amoo et al., 2011). Free 
radicals may also occur as a result of external factors such as air pollution, smoking 
cigarettes, industrial chemicals, and exposure to X-rays (Valko et al., 2007, Lobo et al., 
2010). Some major outcomes of oxidative stress include DNA damage, premature ageing and 
a reduced lifespan (Blomhoff, 2010). Antioxidants are the prime compounds used to 
counteract the effects of oxidative stress (Gupta and Sharma, 2006). Antioxidants are 
produced naturally or may be synthetic (Gupta and Sharma, 2006). Many synthetic 
antioxidants such as butylated hydroxytoluene (BHT), butylated hydroxyanilosole (BHA) and 
tert-butylhydroquinone (TBHQ) have been used by humans and added to their food 
(Amarowicz et al., 2004). However, due to recent discoveries and concerns about their 
toxicity to humans, new ventures and focus have been directed towards finding safer 
alternatives, of antioxidants (Amarowicz et al., 2004, Aremu et al., 2011). In this search for 
natural antioxidants, plants have been named as the best source of natural antioxidants, with 
possibly novel structures possessing unique effective mechanisms of action (Prasad et al., 
2010).  
Plants produce antioxidants as natural chemical bioactive products that can reduce oxidative 
stress (Aremu et al., 2011). Mechanisms of natural antioxidants includes their ability to act 
as reducing agents, free radical scavengers, singlet-oxygen quenchers, chain breakers 
peroxide decomposers metal-chelating agents and hydrogen donors (Rice-Evans et al., 1996, 
Amarowicz et al., 2004, Lobo et al., 2010). 
The use of a single assay to measure antioxidant activity has proven to be unreliable (Mraihi 
et al., 2013), as the reaction of an antioxidant to different radicals and radical sources may 
vary (Mikami et al., 2009). Thus, in this study two complementary and widely used assays 
were used to measure antioxidant activity of extracts from different organs of different 
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Croton species these are the DPPH Radical Scavenging Assay and β-carotene /Linoleic 
assay. 
 
3.4. Materials and methods 
3.4.1. Plant collection and preparation of samples 
Croton species were selected and samples prepared as described in Section 2.2.1 of Chapter 
2.  
 
3.4.2. Extraction of phenolic compounds from plant material 
The extraction of phenolic compounds from dried plant materials was done according to the 
techniques described by Makkar et al. (2000). Two grams (2 g) of finely ground dry plant 
material from each collected plant species and their different organs was extracted with 10 ml 
of aqueous methanol (50%) in a sonication bath for 20 min. with ice added in the sonication 
bath to keep the temperature cool. The extracts were then filtered in vacuo through Whatman 
No. 1 filter papers and stored in air tight pill vials in the dark for further use. 
 
3.4.3. Determination of condensed tannins with the Butanol – HCL assay 
The concentration of condensed tannins in medicinal plant extracts was determined using the 
Butanol – HCL assay (Makkar et al., 2000). In triplicates, 3 ml of the butanol - HCL reagent 
(95:5 v/v) was added to 500 µl of each methanolic extract followed by 100 µl ferric reagent 
(2% ferric ammonium sulphate in 2N HCl). The reaction mixtures were vortexed and 
incubated in a water bath at 100 C for 60 min. A blank containing 500 μl of 50% methanol 
instead of plant extract, mixed with 3 ml butanol-HCl reagent and 100 μl ferric reagent was 
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prepared but without heating. After 1 h, absorbance was measured at 550 nm using a UV-
visible spectrophotometer (Varian Cary 50, Australia). Cyanidin chloride (0.1 mg/ml) was 
prepared in distilled water and used as a standard. The quantity of condensed tannins in each 
sample was then expressed as milligrams (mg) of cyanidin chloride equivalent (CCE) per one 
gram dry weight (g DW) of plant material. 
 
3.4.4. Determination of flavonoid content using the Aluminium Chloride assay 
The total flavonoid concentration of each plant extract was determined using the Aluminium 
Chloride assay as described in Makkar et al. (2000). In three replicates 250 µl of each plant 
extract was pipetted into test tubes and 1 ml of distilled water was added to all the test tubes, 
followed by 75 µl of 5% sodium nitrite (NaNO2), 75 µl 10% aluminium chloride (AlCl3), 0.5 
ml 1 M sodium hydroxide (NaOH) and 0.6 ml distilled water. The mixture was vortexed and 
absorbance was read immediately (no incubation period) at 510 nm using a UV-visible 
spectrophotometer (Varian Cary 50, Australia). A similar preparation for the blank was made 
by adding 50% methanol instead of the plant extract. Catechin (0.1 mg/ml) (Sigma–Aldrich, 
USA) was used as a standard. The flavonoid content was then expressed as milligrams (mg) 
of catechin equivalents (CE) per one gram dry plant material. 
 
3.4.5. Determination of total phenolics using the Folin Ciocalteu (Folin C) assay 
Total phenolics concentration was quantified using the Folin Ciocalteu (Folin C) method as 
described by Makkar et al. (2000), with slight modifications. Folin C reagent (1N) was 
prepared from Folin C (2N) (Sigma - Aldrich, USA) by mixing equal volumes of the Folin C 
(2N) and distilled water in a dark (brown) bottle. Standard gallic acid (Sigma - Aldrich, USA) 
solution was prepared in distilled water at 0.1 mg/ml concentration. The reaction mixture 
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consisted of 50 µl triplicates of each plant extract in test tubes and 950 µl distilled water 
added to make up to 1ml, followed by 500 µl of 1 N Folin C reagent and 2.5 ml of 2% 
sodium carbonate. Similar preparation of a blank containing 50% aqueous methanol and 
different concentrations of gallic acid instead of a plant extract were also prepared. The test 
mixtures were incubated at room temperature for 40 min. Absorbance was then read at 725 
nm using a UV-visible spectrophotometer (Varian Cary 50, Australia). Total phenolic 
concentrations were expressed as gallic acid (GAE) equivalents. The data was analysed using 
Graphpad Prism software (GraphPad version 5.02, San Diego, USA). . 
 
3.4.6. Determination of alkaloids using Thin Layer Chromatography  
Methanolic extracts (80%) were re-suspended in absolute methanol at 50 mg/ml, and 20 µl of 
each extract was spotted on thin layer chromatographic (TLC) plates (5×20 cm, silica gel 60 
F 254, Merck, Germany). The plates were developed in ethyl acetate and methanol (90:10, 
v:v). After developing the TLC plates were air dried and viewed under ultraviolet light (254 
and 366 nm), the florescence was noted and photographed. The TLC plates were then sprayed 
with Dragendorff reagent to determine the possible presence of alkaloids in the extracts. This 
was indicated by the formation of red colouration on the TLC plates (Fawole, 2009).  
 
3.4.7. β-carotene /Linoleic assay  
Antioxidant activity was measured following the method described by Amarowicz et al. 
(2004), with some modifications as described by Moyo et al. (2010). Dried plant extracts and 
the positive control, butylated hydroxytoluene (BHT), were re-dissolved in 50% aqueous 
methanol. Fifty percent aqueous methanol was designated as the negative control. β-carotene 
emulsion was prepared in the dark under a fume hood as follows: In a brown 500 ml Schott 
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bottle covered in foil, 5 mg of β-carotene was dissolved in 0.5 ml chloroform. Excessive 
chloroform was evaporated under vacuum, and a thin layer of β-carotene was left in which 50 
µl linoleic acid and Tween 20 were immediately added. Aerated distilled (124 ml) water was 
added to the mixture to give a final volume of 125 ml. The mixture was vigorously agitated 
until an orange emulsion was formed, with a final β-carotene concentration of 20 µg/ml. The 
β-carotene emulsion (4.8 ml) was dispensed into test tubes, followed by 200 µl of either, 
plant extract, positive or negative controls, making the final concentration of the reaction 
mixture 250 µg/ml. The assay was done in triplicates per sample. The initial absorbance of 
the each reaction mixture was measured immediately with a UV-visible spectrophotometer 
(Varian Cary 50, Australia) at 470 nm (t=0). The tubes were covered with foil and incubated 
at 50°C in a water bath; in the dark; for 3 h. The absorbance for each mixture was measured 
every 30 min. Tween 20 was used as a blank. The rate of β-carotene bleaching was calculated 
according to first order kinetics using the formula: 
                               (
    
    
)       
where At=0 is the absorbance of the emulsion at 0 min; and At=t is the absorbance at time t 
(60, 90 and 120 min). The average rate of β-carotene bleaching was then calculated based on 
rates at 60, 90 and 120 min. The calculated average rates were used to determine the 
antioxidant activity (ANT) of the sample extracts, and expressed as percentage inhibition of 
the rate of β-carotene bleaching using the formula: 
                                        
where Rcontrol and Rsample represent the respective average β-carotene bleaching rates for the 
standard antioxidant and plant extracts, respectively. Antioxidant activity was further 
expressed as the Oxidation rate ratio (ORR) based on the formula: 
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Antioxidant activity (AA) was calculated as described by Braca et al. (2003), based on the 
inhibition of coupled oxidation of β-carotene and linoleic acid against the negative control at 
t= 60 min, t= 90 min and t = 120 min using the formula with the formula:  
    *  (
     
       
)+      
Where A0 is the absorbance of the sample extract at the beginning of incubation; At is the 
absorbance at t=60 and 120 min. for the sample extract and A00 and A0t represent the 
absorbance of the negative control (without sample extract) at the beginning of incubation 
and at time t= 60, t= 60 min and 120 min., respectively. 
 
3.4.8. Determining antioxidant potential using DPPH radical scavenging activity  
The antioxidant activity of the different Croton species extracts was determined using the 
1,1-diphenyl-2-picryl-hydrazyl (DPPH) assay as described by Xie et al. (2010) and Karioti 
et al. (2004) with slight modifications. This assay was used to measure the free radical 
scavenging activity of methanolic extracts of the plants. The assay was performed in 
triplicate, in test tubes and in dim light. Dried methanolic extracts were re-dissolved in 
aqueous methanol. These extracts were diluted with 50% methanol to make a volume of 750 
µl and a further 750 µl of DPPH (0.1 mM in methanol) was added to these diluted extracts 
making final concentrations of the reaction mixture at 6.7, 20, 33, 46.7 and 66.7 µg/ml. 
Similar mixtures were made, where all mentioned contents were added except that methanol 
was substituted for the plant extracts. To make a negative control and positive control the 
plant extracts were substituted with ascorbic (ASC) acid and butylated hydroxytoluene 
(BHT). The background control mixtures consisting of 50% methanol in place of DPPH were 
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made for each extract; these were used to correct any absorbance due to the colour of the 
extract. The mixtures were incubated for 30 min. in the dark at room temperature. After 
incubation, absorbance was read at 517 nm on a spectrophotometer (Varian Cary 50, 
Australia). The background for each extract was corrected by reading the background 
correction mixture after every reaction solution. The radical scavenging activity (RSA) was 
calculated using the following equation: 
     [  (
                    
        
)]      
Where Aextract was the the absorbance of the reaction mixture containing the plant extract or 
the standard antioxidant, Abackground was the absorbance of the background correction mixture 
and Acontrol the absorbance of the negative control. The EC50, which is the concentration of the 
plant extract required to scavenge 50% of the DPPH radicals, was determined using a linear 
regression curve from a graph showing antioxidant percentage (%) inhibition versus the 
concentration of the each sample. 
3.4.9. Statistical analysis 
Analysis of variance (ANOVA) was used to determine the level of significant difference 
(P=0.05) among means and the Duncan‘s multiple range test (DMRT) was used to further 
separate means. The analysis was performed using IBM SPSS (version 26) software. This 
was used to analyse the data from the condensed tannins, flavonoids, phenolics content 
assays as well as the antioxidant activity assays (β-carotene /Linoleic and DPPH Radical 
Scavenging Assays). 
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3.5. Results and discussion 
 3.5.1. Phytochemical evaluation  
Previous studies have reported on the occurrence of a great variety phytochemicals in the 
Croton genus (Ndhlala et al., 2013). These includes various diterpenes (pimarane, clerodane, 
labdane, phorbol esters, tracylobane ) and diterpenoids (Salatino et al., 2007, 
Mukanganyama et al., 2012); cembranoids (Salatino et al., 2007, Langat et al., 2011); 
flavonols (Aderogba et al., 2013, Somit et al., 2013); alkaloids, tannins, phenolics, lignan, 
sterols and anthraquinones (Salatino et al., 2007, Maroyi, 2017). 
The phytochemical content of the Different Croton species collected in KZN and their 
different organs are represented in Table 3.1. Figure 3.4, 3.5 and 3.6 represent the 
variation in the concentrations of condensed tannins, flavonoid, and total phenolics 
respectively across the different Croton species collected in KZN and their different organs.  
 
3.5.2. Condensed tannins content  
The condensed tannins content in evaluated extracts ranged between 0.3±0.1 and 31.3±0.1 
mg CCE/g DW (Fig 3.4 A-B and Table 3.1). Higher quantities of condensed tannins were 
found in leaf extracts of C. gratissimus from Southport and Durban Botanic Gardens 
(31.3±0.1 and 29±0.7 mg CCE/g DW, respectively), as well as from C. pseudopulchellus 
from Mkuze (15.9±0.4 mg CCE/g DW). These and other leaf extracts with high 
concentrations of condensed tannins demonstrated broad-spectrum antibacterial activities 
(Chapter 2, Table 2.2). The current observations could be attributed to higher levels of 
condensed tannins within the assayed leaf extracts. The least condensed tannin content was 
observed in the stem bark extract of C. steenkampianus from Durban Botanic Gardens 
(0.3±0.1 mg CCE/g DW) and twig extracts of C. pseudophulchellus obtained from the same 
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location (0.4±0.1 mg CCE/g DW). Twig and stem bark extracts showed low condensed 
tannin content ranging between 0.3±0.1-5.7±0.3 mg CCE/g DW. Overall the stem bark 
extracts contained the lowest condensed tannins content with none above 5.7±0.3 mg CCE/g 
DW; which was from C. gratissimus from Southport. This is low compared to the content 
exhibited by leaf extracts. 
 
3.5.3. Flavonoid content 
The flavonoid content in evaluated plant extracts ranged from 1.3±0.1-31.1±0.7 mg CE/g 
DW. Represented in Table 3.1. The leaf extracts contained significantly higher concentration 
of flavonoids than other organs, as depicted in Figures 3.5 A- B, and Table 3.1. Leaf 
extracts with highest flavonoid content being C. gratissimus from Southport 31.1±0.7 mg 
CE/g DW, C. sylvaticus from Vernon Crookes N.R. 28.1±0.3 mg CE/g DW, C rivularis from 
Umzumkhulu Valley 27.4±0.2 mg CE/g DW, C. gratissimus from Muden 28±1.0 mg CE/g 
DW and C. menyhartii from Kranskop 26.6±0.6 mg CE/g DW. The antioxidant activity 
(Table 3.2 and 3.3) shown by these plant extracts could be attributed to the flavonoids 
therein. Flavonoids contain a benzopyrone, which is known to be a free radical scavenger 
(Somit et al., 2013). Both twig and stem bark extracts had comparatively lower flavonoid 
content than the other plant organs. The lowest flavonoid content was observed from the stem 
bark and twig extracts of C. steenkampianus obtained from the Durban Botanic Gardens 
(1.3±0.1 and 1.3±0.01 mg CE/g DW respectively). However the twig extracts of C. 
steenkampianus obtained from the Durban Botanic Gardens exhibited noteworthy 
antibacterial activity of 0.31-0.63 mg/ml against E. faecalis and S. aureus (Table 2.2). The 
twigs also showed noteworthy antioxidant activity 63.10±0.88 ANT% (Table 3.2). A similar 
trend was reported in a study conducted by Bojase et al. (2002) and Mulaudzi et al. (2011) 
on Bolusanthus speciosus (Bolus) Harms, where its leaf, stem and bark contained low 
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amounts of flavonoids but exhibited high antibacterial activity against various bacteria. This 
suggests that even in small quantities flavonoids can inhibit bacterial growth. 
3.5.4. Total phenolics content 
The highest phenolic content was recorded in C. pseudopulchellus (Mkuze) leaf extracts 
(28.3±1.1 mg GAE/g DW) whereas the lowest content was observed from C. gratissimus 
(Durban Botanic Gardens) stem bark (1.8±0.1 mg GAE/g DW) as shown in Figure 3.6, and 
Table 3.1. Notably a large number of leaf extracts contained the highest phenolic acids 
content than other plant organs. A significant difference in the total phenolic content and 
general phytochemical content was observed among similar organ extracts of the same 
species. This variation may be due to environmental factors and varying external stress 
experienced by plants in different regions. The yield of biological chemical compounds 
produced is related to type and amount of stress they experience; this includes stresses such 
as drought, sunlight and microorganism. Thus, plants with high stress levels produce high 
concentrations of secondary metabolites (Blomhoff, 2010).  
 
3.5.5. Alkaloid detection  
Plant extracts containing alkaloids are presented in Figures 3.7 and 3.8. Ten out of the 40 
plant extracts evaluated indicated the presence of alkaloids. Alkaloids were detected in the 
following plant parts, leaves of C. gratissimus (Durban Botanic Gardens), twigs of C. 
gratissimus (Southport and Muden), twigs of C. sylvaticus (Southport), leaves and stem bark 
of C. steenkampianus (Durban Botanic Gardens), leaves of C. pseudopulchellus (Durban 
Botanic Gardens), leaves and twigs of C. menyhartii (Kranskop and Mkuze), twigs of C. 
menyhartii (Mkuze) as well as twigs of C. rivularis (Umzumkhulu). Most extracts from the 
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above-mentioned plant parts exhibited noteworthy antibacterial activities (Chapter 2, Table 
2.2), which could, to some extent, be attributed to the presence of alkaloids in the extracts.  
As anticipated several plant extracts that contained higher concentrations of bioactive 
phytocompounds (Figures 3.4,-3.6) exhibited noteworthy antibacterial activities (Chapter 2, 
Table 2.2). Notably the leaves of C. peudopulchellus (Mkuze) and C. gratissimus (Durban 
Botanic Gardens) with MIC values ranging between 0.16–0.63 mg/ml and 0.08–0.94 mg/ml, 
respectively. Certain plants such as the twigs of C. gratissimus (Southport and Durban 
Botanic Gardens), twigs and stem bark of C peudopulchellus (Durban Botanic Gardens) 
exhibited noteworthy antibacterial activity of MIC values ranging between 0.47–0.63 mg/ml, 
0.31–0.63 mg/ml, 0.16–0.63 mg/ml and 0.08–0.63 mg/ml, respectively (Chapter 2, Table 
2.2). These plant extracts, however had low to moderate phytochemical content (Figures 3.4-
3.6). The antibacterial activity of these extracts may be due to other phytochemical 
compounds not screened for in this study or the present phytochemicals may also be highly 
active even in small quantities. Antibacterial activity may also be due to the actions of a 
combination of the available phytochemicals.  
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Table 3.1: Phytochemical properties of Croton species occurring in KZN 






(mg CCE/g DW) 
C. gratissimus Southport Leaves 10,4±0,1 31,1±0,7 31,3±0,1 
 
Twigs 3,1±0,1 5,7±0,3 5,1±0,5 
 
Stem bark 4±,03 6,5±0,2 5,7±0,4 
C. gratissimus D.B.G. Leaves 7,1±1,1 22,9±0,7 29,1±0,7 
 
Twigs 2,8±0,1 2,9±0,1 1,4±0,1 
 
Stem bark 1,8±0,1 2,8±0,1 0,6±0,1 
C.gratissimus Muden Leaves 10±0,5 28±1,0 11,3±0,4 
 
Twigs 3±0,1 3,9±0,1 2,9±0,4 
 
Stem bark 2,7±0,4 4,4±0,1 1,2±0,1 
C. sylvaticus Southport Leaves 14,4±0,1 25,5±0,4 3,5±0,1 
 
Twigs 4,9±0,1 6,0±0,1 0,9±0,1 
C. sylvaticus Umdoni Park Leaves 10,1±0,1 14,6±0,4 2,0±0,1 
 
Twigs 5,9±0,2 4,6±0,1 0,8±0,1 
 
Stem bark 6,2±0,3 7,8±0,3 0,9±0,1 
C. sylvaticus Ntunjambili Leaves 16,4±0,6 6,1±0,1 7,5±0,2 
 
Twigs 5,4±0,2 5,5±0,1 1,1±0,1 
C. syvaticus Vernon Crookes Leaves 17,3±0,5 28,1±0,3 2,4±0,1 
 
Twigs 7,8±0,5 7,6±0,1 0,9±0,1 
 
Stem bark 8,3±0,2 7,5±0,1 1,4±0,1 
C. steenkampianus D.B.G. Leaves 13,7±1,1 3,4±0,1 2,6±0,1 
 
Twigs 6±0,8 1,3±0,1 0,5±0,1 
 
Stem bark 3,2±0,2 1,3±0,1 0,3±0,1 
C. steenkampianus Kosi Bay Leaves 20,3±2,5 3,3±0,1 1,8±0,1 
 
Twigs 8,1±0,4 1,7±0,1 0,7±0,1 
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Table 3.1 Continued….. 






(mg CCE/g DW) 
 
Stem bark 12,7±0,8 2,9±0,1 1,6±0,1 
C. pseudopulchellus Southport Twigs 4,1±0,1 2,1±0,1 0,5±0,1 
C. pseudopulchellus D. B. G. Leaves 11,5±0,6 3,9±0,1 2±0,1 
 
Twigs 5,8±0,5 1,8±0,1 0,4±0,1 
 
Stem Bark 3,6±0,3 1,6±0,1 0,5±0,1 
C. pseudopulchellus Mkuze Leaves 23,8±1,1 23,5±0,4 15,9±0,4 
 
Twigs 8,8±0,8 2,9±0,1 1,3±0,1 
 
Stem bark 10,3±1,4 2,8±0,1 1,7±0,3 
C. menyhartii Mkuze Leaves 7,5±0,6 11,0±0,2 1,9±0,1 
 
Twigs 2,9±0,2 3,5±0,2 0,6±0,1 
 
Stem bark 4,7±0,2 4,3±0,2 1,1±0,1 
C. menyhartii Kranskop Leaves 8,9±0,2 26,6±0,6 8,8±0,2 
 
Twigs 3,2±0,2 4,4±0,1 1±0,1 
 
Stem Bark 2,7±0,1 3,1±0,1 0,5±0,1 
C. rivularis Umzimkhulu Valley Leaves 14,6±0,2 27,4±02 2,8±0,4 
 
Twigs 4,4±0,1 5,6±0,2 0,7±0,1 
Values are the mean ± standard error (n = 3), GAE = gallic acid equivalents, CE = Catechin equivalents, CCE = Cyanide chloride 










1  2   3   4   5 
 
Figure 3.7: TLC plate presenting the red colouration of Dragendorff reagent indicating 
alkaloids in methanolic plant extracts. 1-C gratissimus (leaf) from Durban Botanic Gardens, 
2- C gratissimus (twigs) from Southport, 3-C gratissimus (twigs) from Muden, 4- C. 
sylvaticus (twigs) from Southport, 5-C. steenkampianus (leaves) from Durban Botanic 
Gardens.  
 




6  7   8    9   10 
 
Figure 3.8: TLC plate presenting the red colouration of Dragendorff reagent indicating the 
presence of alkaloids in methanolic plant extracts. 6- C. steenkampianus (stem bark) from 
Durban Botanic Gardens, 7- C. pseudopulchellus (leaves) from Durban Botanic Gardens, 8- 
C. menyhartii (leaves) from Kranskop, 9- C. menyhartii (twigs) from Mkuze 10- C. rivularis 
(twigs ) from Umzimkhulu. 
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3.5.6 β-carotene-Linoleic Acid Model System 
The β-carotene-linoleic acid model system assay is used to determine the antioxidant activity 
of plant extracts by measuring their ability to decrease or inhibit the oxidation of β-carotene-
linoleic acid in an emulsified model system (Shakeri et al., 2012, Ndhlala et al., 2013). 
Oxidation in the β-carotene-linoleic acid emulsion model is heat (50°C) induced. During 
oxidation a hydrogen atom is removed from an active methylene group of linoleic acid, 
resulting in the formation of pentadienyl free radicals (Amarowicz et al., 2004, Moyo et al., 
2010). The free radicals attack the unsaturated β-carotene in order to recover the lost 
hydrogen atom (Ndhlala et al., 2013). As β-carotene reacts with the free radicals it loses its 
hydrogen atom and its orange colour is bleached; a process which could be prevented in the 
presence of antioxidants (Amarowicz et al., 2004, Moyo et al., 2010). As antioxidants have 
the ability to neutralize free radicals, they delay and inhibit bleaching of β-carotene (Moyo et 
al., 2010, Ndhlala et al., 2013). The process can be observed by periodically (every 30 min. 
for 2 h) monitoring the absorbance of a β-carotene-linoleic acid emulsion containing a plant 
extract in a spectrophotometer. The change in the absorbance (decreasing absorbance) with 
time represents the bleaching and oxidation of β-carotene-linoleic acid. The slower it takes 
for β-carotene-linoleic be bleached the higher antioxidant activity is exhibited by the plant 
extract (Amarowicz et al., 2004, Moyo et al., 2010, Ndhlala et al., 2013).  
Table 3.2 presents the antioxidant activities of the evaluated methanolic plant extracts. 
Antioxidant activity of C. gratissimus extract ranged between 63.03 to 81.97% and an ORR 
ranging between 0.18 to 0.37, with C. gratissimus leaf extracts from Muden showing the 
highest ANT% of 81.97% and an ORR of 0.18. The leaf extracts of C. gratissimus showed 
better results when compared with other plant organs of this species, with the exception to of 
C. gratissimus leaf extracts from Southport which exhibited lower antioxidant activity than 
that of the twigs and stem bark. However, all the extracts within this species displayed 
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substantial antioxidant activities. C. gratissimus (Crude 20% MeOH, hexane ethyle acetate, 
butanol) leaf extracts were reported by Ndhlala et al. (2013) to possess the capacity to inhibit 
the oxidation of β-carotene-linoleic acid. 
The ANT % of all C. sylvaticus extracts ranged from 48.66 to 75.75% and ORR ranged from 
0.24 to 0.51. The most potent extract being twig extracts from Ntunjambili and the lowest 
being the leaf extract collected at Vernon Crookes. Antioxidant activity of C. sylvaticus 
extracts was generally high. A modest decrease in antioxidant activity AA was observed over 
time from t=60, 90 and 120 min.  
There were two samples of C. steenkampianus collected from different regions with 
antioxidant activity ranging between 47.49 to 73.62% and ORR from 0.26–0.53. Within this 
species C. steenkampianus stem bark extracts from Durban Botanic Gardens exhibited the 
highest antioxidant activity (73.62%) and the best ORR (0.26). C. steenkampianus Kosi Bay 
leaf extract showed the least antioxidant activity with antioxidant of 47.49% and an ORR of 
0.53. These two C. steenkampianus samples showed a great difference in their antioxidant 
activity. This suggests that species from different localities may not have the same 
phytochemical content and that there are various factors affecting phytochemical content.  
All of the C. pseudopulchellus extracts showed good antioxidant activities which had ANT% 
at 51.58 to 68.11% and ORR from 0.32 to 0.48. The twig extracts of this species exhibited the 
most antioxidant activity compared to the leaf and stem bark extract of the same species. 
C. menyharitii extracts generally yielded high levels of antioxidant activity with ANT% 
ranging between 53.32 to 78.20% and ORR ranging between 0.22 - 0.47. The lowest and 
highest antioxidant activities of this species were both from stem bark extracts of two 
samples from two different regions. The lowest was C. menyhartii stem bark extract from 
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Mkuze and the highest was C. menyhartii stem bark extract from Kranskop. This species did 
not have a definite pattern showing what plant organs were the most active. 
C. rivularis from Umzimkhulu Valley was the only sample of this species that was collected. 
This species showed high antioxidant activity ranging between 80.24% from leaf extract and 
70.40% from the twig extract.  
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Table 3.2: Antioxidant activity of different Croton species collected in KwaZulu-Natal as determined by the β-carotene–linoleic acid model 
system 
Species and locality  Plant part %ANT ORR AA60min AA90min AA120min 




























































































































































































































   
 
 
Table 3.2 continued… 
Species and locality  Plant part %ANT ORR AA60min AA90min AA120min 
































































































































































































































































Values are the mean ± standard error (n = 3), the different letters in a column represent significant differences between the means (P=0.05) 
according to Duncan‘s multiple range test (DMRT). ANT % is antioxidant activity calculated based on the rate at which β-carotene was bleached at 
t=30, 60 and 90 min., this is represented as the percent of bleach inhibition. ORR is oxidation rate ratio, this is the average β-carotene bleaching 
rates as compared to the negative control. The lower the ratio the more active the plant extracts. AA60 and AA120 are antioxidant activities of the 
plant extracts or BHT at t= 60 min and t=120, respectively. Values in bold represent the highest ANT% per species 
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3.5.7. DPPH radical scavenging assay 
Table 3.3 presents EC50 (scavenging activity) of MeOH extracts of different Croton species 
and their different plant parts collected from different localities within KZN. The EC50 values 
were calculated from the dosed dependent radical scavenging activities of these Croton 
extracts, which showed an increase in DPPH radical scavenging activity with an increase in 
extract concentration. The overall EC50 values of the different Croton species and plant part 
ranged from 1.76 to 5.35 µg/ml. The EC50 of the standard antioxidant BHT and ASC used as 
positive control were 1.66 and 1.42, respectively.  
Ndhlala et al. (2013) reported on the radical scavenging activity of the leaf extracts of C. 
gratissimus against DPPH radicals. The results displayed both potency and no radical 
scavenging activity, depending on the solvents used during extraction. Potency was observed 
in C. gratissimus crude extract (20% MeOH), C. gratissimus ethyl acetate, C. gratissimus 
butanol, wheras extracts from solvents hexane and DCM showed no activity. This emphasises 
the significance and effects on plant extract potency that the solvents used for extraction 
have. 
The EC50 values for C. gratissimus in this study ranged from 1.76 to 5.08 µg/ml. The lowest 
EC50 value was from C. gratissimus leaf extract from Southport (1.76 µg/ml) which was not 
significantly different to the positive controls‘ EC50s, and the highest was from C. gratissimus 
stem bark from Muden (5.08 µg/ml). In general, C. gratissimus leaf extracts showed the 
better EC50 compared to the other plant parts ranging between 1.76 to 2.34 µg/ml. 
 
Scavenging activity of all the C. sylvaticus showed EC50 ranges between 2.71 to 5.35 µg/ml. 
C. sylvaticus twigs showed the highest EC50 values (lowest scavenging activity) of analysed 
organs ranging between 4.24 to 5.35 µg/ml.  
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Leaf extracts of C. sylvaticus showed low to moderate scavenging activity with EC50 ranging 
between 2.71 to 4.48 µg/ml. The highest EC50 value (5.35 µg/ml) of C. sylvaticus was from 
twig extracts from Vernon Crookes. It was also the overall lowest free radical scavenging 
activity in this study. 
For the two C. steenkampianus plants tested the EC50 ranged from 3.42 to 4.85 µg/ml. C. 
steenkampianus stem bark extracts from Kosi Bay had the lower EC50 of 3.42 µg/ml in this 
species. The scavenging activities of the different organs in this species yielded no significant 
difference.  
The EC50 of C. pseudopulchellus ranged from 2.67 to 5.18 µg/ml. C. pseudopulchellus leaf 
extract from Mkuze showed the highest free radical scavenging activity in this species with 
its EC50 of 2.67 µg/ml. However, the other leaf extract for this species, from Durban Botanic 
Gardens species, showed the lowest free radical scavenging activity with an EC50 of 5.18 
µg/ml. 
The EC50 values of C. menyhartii ranged from 2.66 to 4.26 µg/ml, where the lowest was EC50 
from C. menyhartii leaf extract from Kranskop (2.66 µg/ml) and the highest from C. 
menyhartii stem bark extracts from Mkuze (4.26 µg/ml). There were no significant 
differences in the EC50 of the plant parts of this species and the EC50 between the plants 
collected in different localities were very similar.  
 
Only one sample of C. rivularis was analysed in the present study. The EC50 of the two 
organs of this species were 3.03 µg/ml for the leaf extract and 3.74 µg/ml for the twig extract.  
Generally most of the species and their organs had good antioxidant activities; whereas there 
were some that had poor activities. C. gratissimus showed higher antioxidant activity in most 
of its organs when compared with the other species. Leaves and twigs showed antioxidant 
activity that was equal or higher than the commonly used stem bark. This supports the notion 
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to consider the use of aerial parts of the plants in efforts to promote sustainable use and 
conservation of plants and other natural resources.   




Table 3.3: 1.1-Diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity (EC50) of 
methanol extracts of various Croton species occurring in KwaZulu-Natal province, South 
Africa 
Species and locality  Plant part EC50(µg/ml) R
2
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Table 3.3 continued….  
Species and locality  Plant part EC50(µg/ml) R
2
 

























































































































  Values are the mean ± standard error (n = 3), the different letters on the values represent significant 
differences between the means (P=0.05) according to Duncan‘s multiple range test (DMRT). R2 
correlation coefficient BHT=butylated hydroxytoluene and ASC=ascorbic acid. The values in bold 
represent the lowest EC50 values (highest scavenging activity) from that species 




Croton species show great variation in their phytochemical constituency and pharmacological 
activities. The plant extracts in the current study generally exhibited activity that validated 
their use in traditional medicine. The species and plant parts that showed low activity may 
require further research and investigation. Some plant extracts such as the stem bark of C. 
gratissimus (Durban Botanic Gardens) and C. menyhartii Kranskop contained the lowest 
amount of phenolic compounds but had previously showed noteworthy antibacterial 
(Chapter 2, Table 2.2) and antioxidant (Table 3.2) activities. Mulaudzi et al. (2011) 
attributed the potency of such plant extracts to the quality of the phenolic compounds and 
suggested that other secondary metabolites may be responsible for the activity. In another 
study a different Croton species, Croton bonplandianus Baill. exhibited a broad spectrum of 
antimicrobial activity which Jeeshna et al. (2011) attributed to the variety of secondary 
metabolites contained by its plant extracts. This included the secondary metabolites screened 
in this study and others which were not screened in this study such as glycosides, steroids, 
saponins and resins, which are known for their therapeutic properties. Croton species are 
known to be rich in secondary metabolites (Rizk, 1987, Jeeshna et al., 2011). For a better 
understanding of the pharmacological activity of the species it would be advantageous wiser 
to screen for a wider variety of secondary metabolites, particularly those that have therapeutic 
activity.  
Further investigation measures to be considered include the use of different solvents for 
extracting plant compounds. It may be beneficial to consider using plants extracted with 
DCM and PE to conduct phytochemical and antioxidant assays as they yielded noteworthy 
activity in antibacterial studies. Methanol was used because it is widely used and has in 
previous studies proven to exhibit high extraction yield for phenolic compounds and 
antioxidants (Yen et al., 1996, Barchan et al., 2014, Truong et al., 2019). Leaf extracts 
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yielded considerable phytochemical and pharmacological activity. This suggests the 
possibility of leaves becoming sources of therapeutic drugs and as possible substitutes for 
bark.  
Chemical composition and quality of the secondary metabolites are not only compromised by 
environmental factors, the degradation and modification of compounds may occur during 
processing, isolation, and storage (Atanasov et al., 2015). For plant extracts that showed low 
secondary metabolites and had previously exhibited noteworthy antimicrobial activity it 
should be considered that these may have been compromised during the processing and 
storage stages. This means careful consideration and caution should be taken during these 
stages




Genotoxicity test for bioactive plant extracts 
 
4.1 Introduction  
An estimated 10
7 
cells divide per second in a human body and a third of these divided cells 
spontaneously mutate (Marnett and Plastaras, 2001). Mutation is the initial and 
fundamental stage in the development of cancer in humans (Lin et al., 1999). Mutation 
occurs when there is an alteration, insertion or deletion of one or a few bases in a gene. It 
may also occur when chromosomes are rearranged or break, or when whole chromosomes are 
lost or gained. Mutation may likewise result when large rearrangement and deletions of DNA 
occur (Mortelmans and Zeiger, 2000). Many mutations in human tissue occur as a result of 
DNA damage usually caused by endogenous processes, such as DNA hydrolysis, exposure of 
DNA to reactive oxygen substances (ROS) and other biological reactive metabolites such as 
oestrogen metabolites and S-adenosylmethionine (SAM) (De Bont and Van Larebeke, 
2004). Most carcinogenic mutations have the capacity to activate oncogenes or deactivate 
tumour suppressor genes (Lin et al., 1999). Mutation are not induced by endogenous 
metabolic processes alone; there are other exogenous factors that humans are exposed to or 
ingest as part of their diet or for therapeutic purposes that have mutagenic and carcinogenic 
potentials. Plants are known to produce a variety of natural chemical compounds, which may 
be cytotoxic and or mutagenic (Ames, 1989).  
   
85 
 
Plants are widely used medicinally and have generally been assumed to be safe, particularly 
because they are natural (Fennell et al., 2004, Awodele et al., 2012). However there are 
growing concerns that the misadministration, misidentification and prolonged use of 
medicinal plants and some herbs may pose a serious threat to consumers. It is important to 
note that while secondary phyto-metabolites may possess therapeutic properties they are 
synthesized by plants as part of their innate defence mechanism. Among other things, these 
compounds poison, deter and/ or kill herbivores and pathogens (Street et al., 2008, Demma 
et al., 2009). It is therefore unreasonable to assume that plants are safe. Scientific researchers 
have documented evidence suggesting that some ethnobotanically significant plants possess 
toxic, mutagenic and/or carcinogenic potentials (Fernandes de Sá Ferreira and Ferrão 
Vargas, 1999, Fennell et al., 2004). Some examples include the phorbol ester found in the 
plant family Euphorbiaceae. This family contains species that are widely used for medicinal 
purposes and herbal teas. However they have been suspected of causing oesophageal cancer 
in Curacao and nasopharyngeal cancer in China (Ames et al., 1990). Aloe vera (L.) Burm.f., 
a widely used herb for bruised skin and internal consumption has likewise been found to be 
toxic to humans. The latex produced by the plant is known to lead to potassium deficiency 
when consumed over a long time, which in turn results in electrolyte imbalances (Haq, 
2004).  
Some compounds produced by plants may have contradictory activities. Examples would 
include phenolics, which are said to be responsible for double-strand DNA breakages, 
chromosome aberrations, DNA and adducts, mutations. They have also been proven to 
produce precancerous lesions, papillomas and act as carcinogens in rodent experiments 
(George, 2011). Phenolics have however, shown actions of carcinogen suppression on 
various carcinogenic compounds (George, 2011). There is however, a relationship to be 
considered between toxicology and pharmacology of plants, Many plants and chemical 
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compounds show therapeutic efficacy at low dosages, but are however toxic when consumed 
at high dosages (Botha and Penrith, 2008, Fred-Jaiyesimi and Ajibesin, 2012). For this 
reason there is a need to further investigate the effects and actions of natural plant material. 
Under certain conditions chemical compounds synthesized by plants are known to react with 
biological metabolites in the human body and may induce mutagenic, cytotoxic and 
genotoxic effects. This is due to their numerous biological properties (Sarkar et al., 1996, 
Celik, 2012).  
The Ames test is a widely used method of examining the mutagenic potential of various 
novel chemical substances. This method has the capacity to detect chemical compounds that 
are responsible for genetic damage which results in gene mutations. Different histidine 
dependent Salmonella tester strains, each containing different mutations in different genes in 
the histidine operon are used to determine the presence of mutagens that produce cells which 
have reverted into histidine independent cells. Salmonella is known to be dependent on 
histidine for its growth. In the assay tester strains are grown in the presence of minimal 
histidine. This is to determine their ability to mutate or revert to histidine independence. This 
is evident by the large number of colonies formed in the Petri-dish (Margolin et al., 1989). 
Plant extracts used in the assay were previously screened for anti-microbial and anti-oxidant 
activity in this research. This section of the study aims to determine the genotoxicity of these 
effective samples.  
 
4.2. Materials and methods 
4.2.1. Plant collection and preparation of samples 
Croton species were collected, samples prepared and extracted as described in Sections 2.2.1 
and 2.2.2 of Chapter 2. On account of limited financial resources, only plant extracts that 
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exhibited noteworthy anti-bacterial activity (MIC < 1mg / ml) were selected to be screened 
for mutagenic properties (Chapter 2, Table 2.2). The biologically active plant extracts were 
re-dissolved in 10% DMSO to make three concentrations of 0.05, 0.5 and 5 mg/ml, 
respectively. 
 
4.2.3. Ames mutagenic test 
Mutagenic properties of plant extracts that exhibited noteworthy anti-bacterial activity with 
minimum inhibitory activity at concentrations of <1mg/ml (Chapter 2, Table 2.2) were 
tested using the Ames mutagenic test assay. The assay described by Maron and Ames 
(1983) and Elgorashi et al. (2003) uses two Salmonella tester strains (TA98 and TA102), in 
the absence of S9 metabolic activation to detect carcinogens and mutagens in plant extracts. 
One hundred microliters of each tester bacterial strain were grown in 10 ml of Oxoid nutrient 
broth No. 2 for 16 h at 37 C on a shaker (100 rpm) to achieve a cell density of approximately 
1 x 10
9 
cfu/ml. In triplicates, 100 µl of different concentrations (0.05, 0.5 and 5mg/ml) of 
each plant extract were dispensed in sterile test tubes, followed by 500 µl of phosphate buffer 
(0.1 mM, pH 7.4), along with 100 µl of the bacterial strain and then 2 ml of sterile melted top 
agar, containing 0.5 mM of biotin and 0.5 mM histidine were added to the mixture. The 
mixture was vortexed and poured onto labelled minimal agar plates and allowed to solidify 
for 2-3 min. One hundred microliters of 10% DMSO served as the negative control and 2 
µg/ml of 4-Nitroquinoline-N-oxide (4-NQO) as a positive control. After solidifying, the 
plates where inverted and incubated at 37°C for 48h. The number of viable colonies was 
counted using a colony counter. The assay was conducted twice and results expressed as 
mean ± standard error number of reverted colonies per plate. Plant samples that produced 
more than twice the number of His+ revertants produced by the negative control were 
considered to be mutagenic (Maron and Ames, 1983). Samples that exhibited a dose-
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dependent increase in the number of His+ revertants in one or two strains were considered to 
be mutagenic (Cariello and Piegorsch, 1996).  
 
4.3. Results and discussion  
Table 4.1 presents the average His+ revertant colonies induced during the Ames mutagenic 
test, where different concentrations (0.05, 0.5 and 5 mg/ml) of crude extracts from Croton 
species were tested for their production of revertant colonies in two S. typhimurium strains 
(TA98 and TA102). The average number of His+ revertant colonies produced by the Croton 
species extracts across all three concentrations ranged from 12.7-68 for TA98 and ranged 
from 201-436 for TA102. The corresponding average number His+ revertant colonies 
produced by the negative control were 34.3 for TA98 and 446.3 for TA102. These results 
suggest that none of the extracts showed mutagenic activity as none of the produced His+ 
revertant colonies were more than twice the number of His+ revertant produced by the 
negative control (10% DMSO). According to the dose dependent growth principle none of 
the extracts showed mutagenic activity in the TA98 strain, however in TA102 three Croton 
extracts showed weak mutagenic activity because there was dose dependent growth across 
the evaluated concentrations (0.05, 0.5 and 5mg/ml). These extracts were from the leaf DCM 
extract of C. steenkampianus (Durban Botanic Gardens), twig PE extracts of C. sylvaticus 
(Southport) and stem bark DCM extract of C. menyhartii (Mkuze). The rest of the extracts 
were non-mutagenic.  
In study conducted by Ndhlala et al. (2013) three compounds isolated from C. sylvaticus 
leaves were tested for mutagenic properties and were found to be non-mutagenic against S. 
typhimurium strains (TA98 and TA100). A similar study was conducted by Verschaeve and 
Van Staden (2008) on the DCM and MeOH leaf and stem extracts of C. sylvaticus where 
   
89 
 
these extracts were found to have no mutagenic activity. While most of the extracts in this 
study did not show mutagenic activity, further investigations are necessary, where different 
toxicological tests will be used to determine mutagenesis of the species as plant extracts are 
complex mixtures and their toxicity may vary with evaluation criteria (Verschaeve and Van 
Staden, 2008). This is also important because Croton species are from the Euphorbiaceae 
family known to produce a wide variety of mammalian toxins, carcinogens and irritants 
(Croteau et al., 2000, Rossi et al., 2003). 
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Table 4.1 Mutagenic evaluation of Croton species extracts using Salmonella typhimurium tester strains (TA98 and TA102) without S9 
metabolic activation. The data is reported as number of histidine independent (His
+
) revertant colonies per plate. 
Values presented as mean±standard error (n=3). DCM = Dichloromethane, MeOH = Methanol, PE = Petroleum ether, 4-NQO = 4-
nitroquinoline-oxide. Value in bold represent extracts with weak mutagenic activity.  
 
 
 Number of His+ revertants/plate (mg/ml) 
  TA98 TA102 
Plant species and locality  Plant extract 0,05 mg/ml 0,5 mg/ml 5 mg/ml 0,05 mg/ml 0,5 mg/ml 5 mg/ml 
C. pseudopulchellus Southport  twigs (MeOH) 13,3±1,9 23,3±11,6 12,7±4,4 366,7±9,8 315±11,0 378,0±11,5 
C. pseudopulchellus Southport  twigs (DCM) 13,7±2,7 17,3±2,7 16,0±4,0 344,3±11,3 349,7±4,9 349,3±14,9 
C. pseudopulchellus Southport  twigs(PE) 18,7±3,2 33,0±4,0 18,7±3,8 325,3±28,9 285,7±5,0 294,7±0,9 
C. gratissimus D.B.G. leaves (DCM) 45,0±4,6 33,7±0,9 17,3±5,0 325,3±14,3 436,7±1,5 275,3±45,0 
C. gratissimus D.B.G. leaves (PE) 51,3±2,4 43,0±2,3 16,3±1,9 349,7±16,3 245±5,5 348,7±28,8 
C. gratissimus D.B.G. twigs(DCM) 44,3±11,7 38,3±3,3 21,0±1,2 333±1,5 279,7±13,9 231,0±20,6 
C. menyhartii Kranskop twigs(PE) 51,0±1,0 31,7±3,8 19,3±2,6 369,3±13,4 369±3,2 201,0±3,5 
C. sylvaticus Vernon Crookes  leaves (DCM) 29,7±1,2 33,3±2,2 20,0±3,1 272±13,3 302,0±23,2 295,7±28,7 
C. steenkampianus D.B.G. leaves (DCM) 33,7±1,5 26,0±3,1 14,3±2,0 259,0±11,5 278,3±9,6 299,0±21,8 
C. sylvaticus Southport  twigs(DCM) 31,0±1,5 29,3±1,5 29,3±1,5 254±6,8 280,7±9,4 267,0±7,5 
C. sylvaticus Southport twig(PE) 33,3±2,4 26,3±3,0 16,7±0,7 254,0±18,2 283,3±20,3 304,3±4,4 
C. steenkampianus D.B.G. leaves (PE) 40,7±8,7 18,7±2,9 23,7±4,9 403±4,6 244,7±14,1 407,3±11,9 
C. pseudopulchellus Mkuze leaves (DCM) 46,3±7,5 19,3±1,5 20,7±1,5 413±11,5 322,3±12,8 375,0±4,6 
C. pseudopulchellus Mkuze leaves (PE) 49,3±8,7 42,3±4,9 33,0±3,5 315,3±11,3 305,7±1,8 366,7±12,4 
C. steenkampianus D.B.G.  twigs(DCM) 68,0±14,4 45,7±3,5 20,3±1,7 308,3±33,2 218,0±20,6 252,0±7,5 
C. menyhartii Mkuze  stem bark (DCM) 68,0±15,4 20,3±2,2 19,7±2,0 242,7±24,9 243,7±14,7 358,3±4,9 
4-nitroquinoline-1-oxide (4-NQO) Positive control  50,7±2,9    352,3±25,5 
 (10% DMSO) Negative control  34,3±3,2    446,3±13,7 
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4.4. Conclusions  
Literature has declared some Croton species toxic (Maroyi, 2017). However results in this 
study have shown that they are not mutagenic. This leaves room for further analysis, perhaps 
using alternative methods of genotoxicity testing. Whereas the results obtained from the 
experiment answer the main question of the safety of the selected Croton species, it also 
emphasizes the significance of evaluating and validating the safety of traditional medicinal 
plants. These plants are used by people for long periods of time and may be the reason for 
development of certain conditions in the long run. Knowing toxicity and mutagenic potential 
plays a crucial role in determining the dosages at which the plants are safe and therapeutic to 
humans. Many of the Croton species in this study have little to no mutagenesis and toxicity 
reports. It is therefore imperative that more safety evaluations be done on this genus. The 
genotoxicity report of this study is based on one test method (Ames test). The Ames test in a 
study by Elgorashi et al. (2002) showed no mutagenic activity in C. sylvaticus extracts 
contrary to the reports of the micronucleus test and comet assay tests which found C. 
sylvaticus to possess mutagenic activity in the same study. This may be due to the complexity 
of the mutation mechanisms and may require technologically advanced tools to be able to 
obtain accurate results (Debnath et al., 1991, Eldeen and Van Staden, 2007). 
 
  




DNA barcoding and molecular phylogeny 
 
5.1. Introduction  
DNA barcoding is a modern technique used to establish the identity of organisms through 
short, standardized DNA sequences of 400-800 bp (base pairs). The application of the DNA 
barcoding technique requires each sequence to be sufficiently variable to distinguish 
individual species, however not too variable within the same species such that a consistent 
boundary can be established between intra- and inter-specific diversities (Savolainen et al., 
2005, Ganie et al., 2015). This analysis of DNA sequences has been a powerful tool in 
reconstructing the phylogenies of many lower and higher plants (Wink, 2003b). It is, 
however, not without its challenges. The greatest challenge with DNA barcoding of plants 
occurs when trying to differentiate between taxa of extremely speciose genera, where species 
recognition rates are rarely greater than 70% when using a range of reputed barcodes. In 
some instances, DNA barcoding groups of diverse newly evolved species can be inadequate 
as an identification method (Kress et al., 2009, Spooner, 2009). The severest cases of this 
challenge are observed in situations where certain aspects of life history have influenced the 
rates of molecular evolution in a population, which may in turn affect species assignment 
rates through DNA barcodes; this includes generation times and age of crown group 
diversification (Kress et al., 2009). 
Nonetheless, DNA barcoding remains the best and most powerful tool for identifying and 
authenticating plants and animals. This is due to DNA being an exceedingly stable 
micromolecule that is seldom affected by external factors, hence can be extracted from 
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biological material of varying states such as fresh, dried, and processed. Furthermore, the 
markers are not tissue-specific and can be identified at any point in the organism's growth. 
Only a small volume of sample is required for analysis. (Heubl, 2010, Tripathi et al., 2011, 
Techen et al., 2014). DNA barcoding is often used by plant taxonomists or systematists and 
is also a valuable tool for forensics experts, customs agents, and traditional drug suppliers 
(Chen et al., 2010). DNA barcoding is a suitable support method of taxonomic identification 
as it may assist in instances where no taxon or biodiversity experts are available. It may also 
help in cases where there is a high level of morphological similarity between closely related 
species such that it is almost impossible to distinguish them without their reproductive organs 
such as flowers and fruits and these are not always presented during field surveys 
(Parmentier et al., 2013).  
 
5.2. Phylogeny and secondary metabolites 
Researchers have studied the connection between plant species evolution and their secondary 
metabolites for almost 200 years. Because of their nature and function as natural chemical 
defences of plants, it is believed that they are characters that underwent natural selection 
during evolution (Wink, 2003b). The variation and distribution of secondary metabolites 
among plant species is part of the evolution of plants. Different plants developed various 
chemical compounds as a result of herbivores and herbivorous insects that target certain 
plants (Nyman and Julkunen-Tiitto, 2005, Rønsted et al., 2012). Many researchers have 
used chemical similarities to deduce relationship between plant species (Wink, 2003b, 
Nyman and Julkunen-Tiitto, 2005, Maldonado et al., 2017). However, there have been 
concerns about the reliability of the chemical data in phylogenetic inference due to the 
sporadic occurrence of specific compounds in totally unrelated plant species (Nyman and 
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Julkunen-Tiitto, 2005). In a study conducted by Maldonado et al. (2017), genetic variation 
was the leading cause of alkaloid content variation within Cinchona calisaya. DNA based 
phylogenies have proven to be the best classification tools and could be diversified for use in 
ethnobotany by improving medicinal plant identification and bio-prospecting through further 
investigation of the correlation of medicinal plant phytochemistry or secondary metabolites 
and their DNA based phylogenies (Rønsted et al., 2008). 
 
5.3 Phylogenetic study of th Croton species of KwaZulu-Natal 
Croton is one of the largest genera of flowering plants, consisting of herbs, shrubs, trees, and 
rarely lianas (Berry et al., 2005). It belongs to the family Euphorbiaceae, known for its 
species richness, morphological and phytochemical diversity and commercial importance 
(Wurdack et al., 2005). The high diversity and its global distribution have proven to be a 
challenge for the subgeneric classification of Croton (Webster, 1993, Webster et al., 1996). 
Diagnostic morphological characters for Croton include conspicuous scalelike or starlike 
trichomes, narrow or condensed inflorescence with unisexual flowers, clear to coloured latex, 
frequent petiolar glands, and senescent leaves that turn orange before abscising (Berry et al. 
2005). 
The current study aimed to determine barcodes for and the phylogenetic affinities of all 
Croton species naturally occurring in KwaZulu-Natal. DNA barcodes of properly vouchered 
and locally sourced specimens were produced in order to allow future characterisation of 
material that cannot easily be identified morphologically such as bark, leaves or roots. The 
phylogenetic relationships were compared with their pharmacological and phytochemical 
properties. They were used to determine whether closely related Croton species contain 
similar phytochemical compounds and whether they occur in similar quantities. Previous 
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researchers have suggested that the lineage distribution of plants is shaped by bioactivity. 
Furthermore, studies have demonstrated the presence of similar medicinal and chemical 
properties (Saslis-Lagoudakis et al., 2012). This has led to the use of plant phylogenies in 
bio-prospecting, with the expectation that plants that occur in the same clade in a phylogeny 
would have similar medicinal properties (Hawkins and Teixidor Toneu, 2017).  
In the current study, two regions were sequenced and used in a phylogenetic analysis of 
Croton as described by van Ee et al. (2015), the nuclear ribosomal Internal Transcribed 
Spacer (ITS) and the chloroplast trnL-trnF intergenic spacer (trnL-F). These markers have 
been previously used in several Croton analyses and have proven suitable for phylogenetic 
study at species level (Berry et al., 2005, van Ee and Berry, 2009, van Ee et al., 2015). The 
nuclear and chloroplast regions are often used to study the evolutional relationship between 
related species. The current study further aimed to determine the phylogenetic relationship of 
the KZN Croton genus and extend on the work done by Haber et al. (2017), who focused on 
the African and Western Indian Ocean (WIO) species. Phylogenetic placement of the KZN 
species will allow us to assess whether the phytochemical and secondary metabolite profile of 
Croton species is clade-specific. 
 
5.4. Material and methods 
5.4.1. DNA extraction, amplification, and sequencing 
DNA of six representative Croton species was extracted from silica-dried leaf tissue using the 
Zymo Research Quick-DNA
TM
 Plant/Seed Miniprep Kit, following the manufacturer‘s 
protocol. The quality and concentration of the extracted DNA was examined with a 
NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific, Wilmington, Delaware, 
USA). The ITS and trnL-F regions were amplified by the Polymerase chain reaction (PCR) 
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using a Veriti 96-Well Thermal Cycler (Applied Biosystems, Life Technologies, Carlsbad, 
California, USA).  
5.4.2. Amplification of the nuclear ribosomal internal spacer (ITS) marker 
The ITS region was amplified using the primer pair ITS4 and ITS5 (White et al., 1990) to 
sequence in both directions. The PCR reaction contained: 12.5 µl of the One Taq Quick-load 
2X Master mix (New England BiolLabsInc.), 0.5 μM forward primer, 0.5 μM reverse primer, 
10.5 µl nuclease-free water, and 1 µl of DNA, making a total of 25 µl. The PCR thermo-
cycling conditions were: 30 seconds initial denaturation at 94°C; 35 cycles of 30 seconds 
denaturation at 94°C; 1-min. annealing at 53°C and 1 min. of elongation at 68°C; followed by 
5 min. of final elongation at 68°C. 
 
5.4.3. Amplification of plastid marker trnL-F 
The plastid marker trnL-F was amplified using the e and f primer pair (Taberlet et al., 1991) 
sequencing from both directions. The PCR reaction was as above (5.4.2) except that the 
primers e and f were used here. The PCR thermo-cycling conditions were: 30 seconds initial 
denaturation at 94°C; 35 cycles of 30 seconds denaturation at 94°C; 1-min. annealing at 55°C 
and 1 min. of elongation at 68°C.; followed by 5 min. of final elongation at 68°C. 
 
5.4.4 Gel electrophoresis  
PCR products (1µL) were visualised by electrophoresis with 1% agarose gels run in 1X TBE 
buffer at 100V for 45 min. DNA was visualised by adding Gel Red nucleic acid gel stain 
(Biotium Inc., Fremont, California, USA) to the PCR sample. 




The PCR products and the respective primers (1.1µM) used for amplification were sent to the 
DNA Sequencer Unit at the Stellenbosch University Central Analytical Facility (CAF) for 
sequencing.  
 
5.5. Phylogenetic analyses 
Upon receiving sequence chromatograms from CAF, they were assembled and edited in 
Sequencher v4.1.4 (Gene Codes Corp., Ann Arbor, Michigan, USA). The sequences were 
then inserted into the alignment from Haber et al. (2017) provided to for this study van Ee 
(personal communication). The ClustalW Multiple alignment function in BioEdit v.7.2.5 was 
used to align the sequences followed by manual alignment where necessary (Hall, 1999). 
Only the ITS and trnLF parts of the Haber et al. (2017) alignment were used. 
Phylogenetic relationships were inferred using Bayesian Inference performed under best 
model parameters using MRBAYES on XSEDE (v3.2.1a) available in the CIPRES Science 
Gateway V. 3.3 (Miller et al., 2010). The analysis was performed using two independent 
parallel runs, consisted of 10 million MCMC generations, and was sampled for every 1000 
generations. Convergence between runs was assessed by checking the effective sample size 
(ESS > 200) of each parameter and the log-likelihood (LnL) values, using Tracer v1.7 
(Rambaut et al., 2018). The first 25% of generations were discarded from the burn-in, and 
majority-rule consensus trees with posterior probability (PP) were generated. Clades with PP 
≥ 95% are strongly supported (Huelsenbeck and Ronquist, 2001).  
Additionally, a maximum likelihood (ML) analysis was conducted using RAxML 
(Stamatakis, 2014) in the CIPRES Science Gateway, using the GTRCAT substitution model 
and 1000 bootstrap replicates for statistical support. The ML and Bayesian trees were then 
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visualized and edited using FigTree v 1.4.2. (Rambaut, 2012) Clades with bootstrap support 
(BS) ≥ 70% were considered strongly supported (Hillis and Bull, 1993). 
 
5.6. Results and discussion 
Six ITS and six trnL-F sequences from six different Croton species occurring in KZN were 
newly generated and incorporated into the ITS and trnL-F matrix of Haber et al. (2017) 
bringing the total number of terminals to 129 Croton taxa and two outgroups. The aligned 
and partitioned dataset contained 1793 base pairs (bp), in which the ITS sequences 
contributed 704 bp and the trnL-F sequences contributed 1089 bp.  
Figure 5.1 shows the majority rule consensus Bayesian inference (BI) tree. Figure 5.2 
presents the maximum likelihood tree. The majority rule Bayesian inference tree of Croton 
from the study of Haber et al. (2017) is presented in Figure 5.3. It should be noted that the 
latter shows more resolution as it is based of four DNA regions.  
The phylogenetic tree revealed that sequences generated for C. sylvaticus, C. gratissimus, and 
C. menyhartii from KwaZulu-Natal match the sequences generated for the same species from 
a different geographic region in the study of Haber et al. (2017). However, this is not the 
case for C. pseudopulchellus from KZN, which is not sister to C. pseudopulchellus from 
Haber et al. (2017). When comparing the neighbouring species of the two C. 
pseudopulchellus specimens in Figure 5.1 and Figure 5.3, the two specimens were found to 
be relatively closely related; however, they are clearly different. Several explanations are 
possible. One possibility is that the Haber specimens may have been misidentified. The 
identity of the specimen used in this study was confirmed by G. Nichols and B. Bytebier and 
was confirmed to be C. pseudopuclhellus. The specimen in Haber et al. (2017) came from 
Tanzania and an alternative explanation could perhaps be that the genetic variation in C. 
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pseudopulchellus may have been underestimated, such that cryptic species may be hidden in 
the current concept of the C. pseudopulchellus. Nevertheless, the difference in the barcode 
sequences for two specimens supposedly belonging to the same species highlights the need 
for having regionally acquired material as the source of DNA sequences if misidentification 
on the basis of the barcode is to be avoided. 
C. rivularis and C. steenkampianus appear to be sister species. These two species were not 
similar in their antimicrobial activity. C. steenkampianus showed some notable activity 
whereas C. rivularis showed no activity (Table 2.2). On the other hand, C. rivularis showed 
noteworthy antioxidant activity, whereas C. steenkampianus only moderate antioxidant 
activity (Table 3.2). Phytochemicals contained in these species were similar for some 
compounds and different for others. For example, they contained similar amounts of 
condensed tannins and phenolics in their leaves and stem barks but different quantities of 
flavonoids (Figures 3.4-3.6). There have been some similarities observed in the 
phytochemistry of these two sister species. However, the dissimilarities that occur suggest 
that although some species are closely related, they may not always contain the same 
phytochemical quantity and quality.  
Because our phylogenetic analysis was only based on two gene regions (instead of four in 
(Haber et al., 2017)), our tree is less resolved. As a result, all the species from KZN, South 
Africa, appeared in the same clade (Clade V, Figure 5.1) apart for C. sylvaticus, which 
appeared in a sister clade (Clade IV, Figure 5.1). It was further observed that even though 
these Croton species are in the same clade, they may not be closely related, particularly not if 
we consider where they would be placed in the better resolved phylogeny of Haber et al. 
(2017). Therefore, they may not be expected to have the same phytochemical properties. 
Pharmacological and phytochemical investigations conducted on Croton species from KZN, 
South Africa, in Chapters 2 and 3 revealed that all the species contained the same 
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phytochemical properties. These include phenolics, flavonoids, condensed, and tannins 
(Chapter 3). However, they varied in their quantity and distribution across the various plant 
parts. These species also demonstrated antioxidant activity.  
  




Figure 5.1: Majority rule consensus tree from Bayesian MCMC inference from combined 
ITS and trnL-F sequences of Croton species and two outgroups. Values above the branches 
represent posterior probability (PP), strongly supported branches (PP ≥0.95).I-V=clades. 




Figure 5.2: Maximum Likelihood phylogenetic tree Croton species constructed with 
RAxML, with DNA markers ITS and trnL-F. The numbers above the branches represent 
bootstrap support percentages. On the right of the tree is the distribution of the main clades. I-
V=clades.  




Figure 5.3: Majority rule consensus tree from the Bayesian MCMC inference for Croton 
WIO spp. of the combined ITS and plastid results. Above the branches, bootstrap values from 
ML analyses are indicated, and corresponding posterior probabilities below the branches are 
provided (Haber et al., 2017). 





Studies of this nature are conducted for various reasons, such as determining plant 
identification, plant authentication, and plant relationship determination. The current research 
has shown that DNA barcodes may not always be the best tool to identify medicinal plants 
with potentially valuable phytochemicals. The phylogenetic tree revealed that the Croton 
species from KZN are not closely related except for C. steenkampianus and C. rivularis. 
Though results in Chapter 3 revealed that the different Croton species contained the same 
phytochemicals, there was high variation in the levels. Phytochemical quantities and quality 
may vary due to different environmental stimuli that trigger specific phytochemical 
production. There was also variation in the phytochemical distribution in the different plant 
organs. A close phylogenetic relationship between species does not signify the same 
phytochemistry but a similarity. This means more assays need to be conducted to confirm 
phytochemical properties. 
Several other Croton species closely related to the Croton species from KZN have been used 
for medicinal purposes in their areas. Many of the uses listed for these species are similar to 
those of the Croton species from KZN. These species include Croton megalocarpus Hutch.- 
which is used as an anthelmintic agent and to treat whooping cough (Addae-Mensah et al., 
1992), coryza sinusitis, and pneumonia (Matu and Van Staden, 2003, Schmelzer and 
Gurib-Fakim, 2008). Croton socotranus Balf.f. is used to heal wounds and is used as an 
anthelmintic agent (Bakthir et al., 2011, Mothana et al., 2012). Croton tiglium L. is used as 
a purgative, is used to treat fever, sore throat, dysentery, and cancerous tumors (Schmelzer 
and Gurib-Fakim, 2008). The evidence gathered in this study suggests that Croton species 
may sometimes be used as substitutes of one another for therapeutic use. However, efficacy 
might not be the same.  
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DNA barcodes for KZN Croton species have been developed to be deposited in the Genbank 
for future use as references. It is vital to have regional representative DNA for widespread 
species. This was seen in the DNA results for C. pseudopulchellus, which revealed that the 
same species in different geographic regions might not be genetically identical. This may 
require further investigation to determine whether these are indeed the same species. DNA 
barcodes are useful in medicinal plant authentication. 
  






Many researchers have studied medicinal plants, their use, and their contribution to the 
livelihoods of people all over the world (Shinwari and Qaiser, 2011). However, concerns 
about the loss of medicinal plants in their natural habitat remain. Studies focused on the 
conservation and sustainable use of these valuable renewable resources and their habitat have 
fallen behind increasing demand for medicinal plant research (Hamilton, 2004). To ensure a 
continuous supply of herbs from nature, as well as maintaining medicinal plant species 
diversity,ethnobotanical studies should integrate a conservation and sustainability approach. 
This study aimed at finding possible solutions for plant exploitation studying and comparing 
phytochemical and pharmacological properties of six Croton species occurring in KwaZulu-
Natal; as well as testing and comparing the phytochemical and pharmacological activities of 
various plants organs of these six species. This was done to determine whether the aerial 
organs such as leaves and twigs could be used instead of organs such as the bark which 
involves destructive harvesting. Additionally the study compared the phytochemical and 
pharmacological properties of the different Croton species to determine whether they could 
be substituted for one another, thus trying to reduce destructive sampling of any given 
species. Phytochemicals such as condensed tannins, phenolics, flavonoids, and alkaloids were 
tested for and the former three were quantified and compared to find out whether they occur 
in similar amounts in closely related Croton species. To some extent, the current research 
findings validated the use of Croton species in traditional medicine as almost all of the 
Croton species tested, apart from C. rivularis, showed noteworthy inhibitory activity against 
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various test microbes (S. aureus, E. faecalis, and K. pneumonia). The results also showed that 
a more sustainable use of the species is possible as most of the leaves and twigs of the various 
Croton species showed higher inhibitory activity than the stem bark, which is the most 
commonly used part of the plant in traditional medicine. Only one species showed similar or 
higher inhibitory activity from its stem bark than that exhibited by leaves and twigs. These 
noteworthy antibacterial activities displayed by the stem bark were from the DCM and PE 
extracts of C. pseudopulchellus collected from the Durban Botanic Gardens. Their MIC was 
0.08 and 0.04 mg/ml, respectively, against S. aureus and E. faecalis. Only one extract showed 
noteworthy inhibitory activity against the fungus C. albicans. This was from the MeOH leaf 
extracts of C. steenkampianus collected at Kosi Bay with a MIC of 0.6 mg/ml.  
The study further revealed variations in the pharmacological and phytochemical properties of 
the same Croton species collected from different localities. This was most likely attributed to 
the variation in the environmental stimuli experienced by species in different regions. 
Phytochemical studies revealed that the Croton species under investigation contained varying 
concentrations of secondary metabolites. These included condensed tannins, flavonoids, 
phenolics and alkaloids. Here, a similar pattern as in the antimicrobial assay was observed, 
where leaves and twigs displayed higher compound content than stem bark. Variation in the 
phytochemical profiles of the same species collected from different regions was also 
observed. This suggests that the phytochemicals present in the plant extracts vary according 
to the habitat in which they grow.  
The two antioxidant activity assays, β-carotene-Linoleic Acid Model System and DPPH 
radical scavenging assay tested on the Croton species demonstrated the presence of 
antioxidant activity for all these species (Table 3.2). Some of the antioxidant activity was 
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noteworthy, for other species moderate and few were low, with ANT% ranging between 
47.49 to 81.97 %. 
Croton species have proven worthy of their popularity and are commonly used by traditional 
healers. However, efficacy alone does not make a good medicinal plant. Further 
investigations were performed to determine the safety of these medicinal plants. The plant 
extracts that showed noteworthy biological activities were further tested for mutagenic 
activity. The results of the Ames mutagenic test conducted on the Croton extracts 
demonstrated no evidence of mutagenic behaviour on two Salmonella test strains (TA98 and 
TA102). This shows the plants to be safe but only in terms of mutagenic potential. More 
toxicity tests need to be conducted as there are various ways in which a plant may be harmful. 
This is more especially with previous reports stating Croton species to be toxic (Selowa et 
al., 2010). 
Many researchers believe that related species ought to have similar chemical properties. 
Against this expectation, a phylogenetic tree was constructed with sequences of the Croton 
species from KwaZulu-Natal and the sequence of Croton species from a study by Haber et 
al. (2017). The tree was studied to determine how closely related the KZN Croton species are 
and whether they possessed the same chemical properties. The results revealed that even 
though the species were related, they did have similar chemical properties; however, they 
were not the same quantities. Thus the species did not exhibit the same pharmacological 
activity. 
Overall findings of the study showed that Croton species are possible candidates for 
medicines; however, further research is required to fully understand the potential of this 
genus. It is important to consider that traditional healers use a combination of various 
medicinal plants to maximise the effectiveness of their therapeutic medicines, and this is 
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where plant extracts perform more effectively. Future studies of medicinal plants should 
include research into synergy of plant extract. 
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